{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/descartesmbogning/Named-Entity-Recognition-NER-/blob/main/clinicaltrial_extract_diseases_new_data.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "j7nUM_BMRY1D"
      },
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "import numpy as np\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Gdy8NI_lSZEb"
      },
      "outputs": [],
      "source": [
        "import spacy\n",
        "import codecs\n",
        "import re\n",
        "#from wordcloud import STOPWORDS\n",
        "\n",
        "#import nltk\n",
        "#from nltk.corpus import stopwords\n",
        "#from nltk.stem import WordNetLemmatizer\n",
        "\n",
        "#from sklearn.feature_extraction.text import TfidfVectorizer, CountVectorizer\n",
        "#from sklearn import decomposition\n",
        "#from nltk.stem.porter import PorterStemmer"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "3m_8ZWnbL0Et",
        "outputId": "9c4cc3fc-2157-4239-9388-74b07a9b7c5e"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Mounted at /content/drive\n"
          ]
        }
      ],
      "source": [
        "from google.colab import drive\n",
        "drive.mount('/content/drive')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "lHQj7jnOiQ30"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "g3INQ_pniQ73"
      },
      "outputs": [],
      "source": [
        "#pip install taxonerd"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "IgDnYwE6iWbu"
      },
      "source": [
        "Import and concatenate data files of each year in year file"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 678
        },
        "id": "XDD_u9mriQ_i",
        "outputId": "71e2d92b-aea5-4f17-8c43-733de9d4a156"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "109\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "0  Rank        Trial ID                                              Title  \\\n",
              "1   675     NCT05948592  A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2   764     NCT05973721  To Investigate the Clinical Efficacy and Safet...   \n",
              "3   622     NCT05967130  Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4   195  ISRCTN18158855  Evaluating the diagnostic utility of Actiphage...   \n",
              "5  1042     NCT05537519  Phage Therapy for the Treatment of Urinary Tra...   \n",
              "\n",
              "0                                        Brief title   Acronym  \\\n",
              "1  Bacteriophage Therapy TP-102 in Patients With ...  REVERSE2   \n",
              "2  Clinical Study of Phage Therapy for Chronic Co...       NaN   \n",
              "3       Treatment Chronic UTI Post Kidney Transplant       NaN   \n",
              "4  Evaluating the performance of blood-based test...  PHAGE-TB   \n",
              "5  Phage Therapy for the Treatment of Urinary Tra...       NaN   \n",
              "\n",
              "0                                           Abstract  Start date Start Year  \\\n",
              "1  TP-102 is a novel bacteriophage cocktail compr...  2023-08-01       2023   \n",
              "2  The overall aim was to evaluate the efficacy o...  2023-07-01       2023   \n",
              "3  Urinary tract infections (UTIs) with extended-...  2023-07-01       2023   \n",
              "4  Background and study aims \\nTuberculosis (TB) ...  2023-05-05       2023   \n",
              "5  This is a single-patient, phase I/II clinical ...  2023-05-01       2023   \n",
              "\n",
              "0    End Date Completion Year      Phase      Study Type  \\\n",
              "1  2023-12-31            2023    Phase 2  Interventional   \n",
              "2  2023-10-01            2023        NaN  Interventional   \n",
              "3  2024-07-01            2024    Phase 3  Interventional   \n",
              "4  2024-07-30            2024        NaN   Observational   \n",
              "5  2025-12-30            2025  Phase 1/2  Interventional   \n",
              "\n",
              "0                                       Study Design  \\\n",
              "1  Allocation: Randomized; Intervention Model: Pa...   \n",
              "2  Allocation: N/A; Intervention Model: Single Gr...   \n",
              "3  Allocation: N/A; Intervention Model: Single Gr...   \n",
              "4  Allocation: Cohort Study; Primary Purpose: Dia...   \n",
              "5  Allocation: N/A; Intervention Model: Single Gr...   \n",
              "\n",
              "0                                         Conditions      Recruitment Status  \\\n",
              "1                            Diabetic Foot Infection      Not yet recruiting   \n",
              "2       Pib Specific Phage; Intractable Constipation              Recruiting   \n",
              "3  Urinary Tract Infections; Transplant-Related D...              Recruiting   \n",
              "4           Diagnosis of active tuberculosis disease                     NaN   \n",
              "5                  Recurrent Urinary Tract Infection  Active, not recruiting   \n",
              "\n",
              "0 Number of Participants                          Intervention  Gender  \\\n",
              "1                     80  TP-102 (Biological), Placebo (Other)     All   \n",
              "2                     50                    phage (Biological)     All   \n",
              "3                     20                    Phage (Biological)     All   \n",
              "4                    103                                   NaN     All   \n",
              "5                      1            Phage Therapy (Biological)  Female   \n",
              "\n",
              "0                  Age            Registry Investigators/Contacts  \\\n",
              "1       18 Years - N/A  ClinicalTrials.gov      Jose David Suarez   \n",
              "2  18 Years - 70 Years  ClinicalTrials.gov         Hongliang Tian   \n",
              "3            N/A - N/A  ClinicalTrials.gov                 Dalili   \n",
              "4          None - None              ISRCTN                    NaN   \n",
              "5       18 Years - N/A  ClinicalTrials.gov         Gregory German   \n",
              "\n",
              "0                             Sponsors/Collaborators  \\\n",
              "1                         Technophage, SA; VectorB2B   \n",
              "2  Shanghai 10th People's Hospital; Shanghai Tent...   \n",
              "3  Shahid Beheshti University of Medical Sciences...   \n",
              "4  University of Leicester; PBD Biotech Limited; ...   \n",
              "5  Unity Health Toronto; Applied Health Research ...   \n",
              "\n",
              "0                      GRID IDs City of Sponsor/Collaborator  \\\n",
              "1                            ;                            ;    \n",
              "2               ; grid.412538.9                   ; Shanghai   \n",
              "3               grid.411600.2;                Tehran; Tehran   \n",
              "4  grid.9918.9; ; grid.269014.8       Leicester; ; Leicester   \n",
              "5             ; ; grid.416449.a                  ; ; Toronto   \n",
              "\n",
              "0 State of Sponsor/Collaborator   Country of Sponsor/Collaborator  \\\n",
              "1                            ;                                 ;    \n",
              "2                            ;                            ; China   \n",
              "3                            ;    Iran; Iran, Islamic Republic of   \n",
              "4                          ; ;   United Kingdom; ; United Kingdom   \n",
              "5                   ; ; Ontario                        ; ; Canada   \n",
              "\n",
              "0                           Collaborating Funders Funder Group  \\\n",
              "1                                             NaN          NaN   \n",
              "2                                             NaN          NaN   \n",
              "3  Shahid Beheshti University of Medical Sciences          NaN   \n",
              "4                         University of Leicester          NaN   \n",
              "5                                             NaN          NaN   \n",
              "\n",
              "0  Funder Country                               Source Linkout  \\\n",
              "1             NaN  https://clinicaltrials.gov/show/NCT05948592   \n",
              "2             NaN  https://clinicaltrials.gov/show/NCT05973721   \n",
              "3            Iran  https://clinicaltrials.gov/show/NCT05967130   \n",
              "4  United Kingdom        https://www.isrctn.com/ISRCTN18158855   \n",
              "5             NaN  https://clinicaltrials.gov/show/NCT05537519   \n",
              "\n",
              "0 Altmetric Attention Score  \\\n",
              "1                       NaN   \n",
              "2                       NaN   \n",
              "3                       NaN   \n",
              "4                       NaN   \n",
              "5                       247   \n",
              "\n",
              "0                                     Dimensions URL  \\\n",
              "1  https://app.dimensions.ai/details/clinical_tri...   \n",
              "2  https://app.dimensions.ai/details/clinical_tri...   \n",
              "3  https://app.dimensions.ai/details/clinical_tri...   \n",
              "4  https://app.dimensions.ai/details/clinical_tri...   \n",
              "5  https://app.dimensions.ai/details/clinical_tri...   \n",
              "\n",
              "0                   Fields of Research (ANZSRC 2020)  \\\n",
              "1  31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "2  32 Biomedical and Clinical Sciences; 3202 Clin...   \n",
              "3  31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "4  4203 Health Services and Systems; 32 Biomedica...   \n",
              "5  3207 Medical Microbiology; 32 Biomedical and C...   \n",
              "\n",
              "0                                    RCDC Categories  \\\n",
              "1  Emerging Infectious Diseases; Clinical Researc...   \n",
              "2                                 Digestive Diseases   \n",
              "3  Urologic Diseases; Infectious Diseases; Transp...   \n",
              "4  Biodefense; Clinical Research; Infectious Dise...   \n",
              "5  Infectious Diseases; Clinical Research; Urolog...   \n",
              "\n",
              "0               HRCS HC Categories  \\\n",
              "1                        Infection   \n",
              "2                              NaN   \n",
              "3  Renal and urogenital; Infection   \n",
              "4                        Infection   \n",
              "5  Infection; Renal and urogenital   \n",
              "\n",
              "0                                HRCS RAC Categories Cancer Types  \\\n",
              "1  5.1 Pharmaceuticals; 6.1 Pharmaceuticals; 6.2 ...          NaN   \n",
              "2                                5.1 Pharmaceuticals          NaN   \n",
              "3                                                NaN          NaN   \n",
              "4  4.2 Evaluation of markers and technologies; 4....          NaN   \n",
              "5           6.1 Pharmaceuticals; 5.1 Pharmaceuticals          NaN   \n",
              "\n",
              "0 CSO Categories  \n",
              "1            NaN  \n",
              "2            NaN  \n",
              "3            NaN  \n",
              "4            NaN  \n",
              "5            NaN  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-90578f25-823c-481a-93d8-b1940a909434\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Rank</th>\n",
              "      <th>Trial ID</th>\n",
              "      <th>Title</th>\n",
              "      <th>Brief title</th>\n",
              "      <th>Acronym</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Start date</th>\n",
              "      <th>Start Year</th>\n",
              "      <th>End Date</th>\n",
              "      <th>Completion Year</th>\n",
              "      <th>Phase</th>\n",
              "      <th>Study Type</th>\n",
              "      <th>Study Design</th>\n",
              "      <th>Conditions</th>\n",
              "      <th>Recruitment Status</th>\n",
              "      <th>Number of Participants</th>\n",
              "      <th>Intervention</th>\n",
              "      <th>Gender</th>\n",
              "      <th>Age</th>\n",
              "      <th>Registry</th>\n",
              "      <th>Investigators/Contacts</th>\n",
              "      <th>Sponsors/Collaborators</th>\n",
              "      <th>GRID IDs</th>\n",
              "      <th>City of Sponsor/Collaborator</th>\n",
              "      <th>State of Sponsor/Collaborator</th>\n",
              "      <th>Country of Sponsor/Collaborator</th>\n",
              "      <th>Collaborating Funders</th>\n",
              "      <th>Funder Group</th>\n",
              "      <th>Funder Country</th>\n",
              "      <th>Source Linkout</th>\n",
              "      <th>Altmetric Attention Score</th>\n",
              "      <th>Dimensions URL</th>\n",
              "      <th>Fields of Research (ANZSRC 2020)</th>\n",
              "      <th>RCDC Categories</th>\n",
              "      <th>HRCS HC Categories</th>\n",
              "      <th>HRCS RAC Categories</th>\n",
              "      <th>Cancer Types</th>\n",
              "      <th>CSO Categories</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>675</td>\n",
              "      <td>NCT05948592</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>Bacteriophage Therapy TP-102 in Patients With ...</td>\n",
              "      <td>REVERSE2</td>\n",
              "      <td>TP-102 is a novel bacteriophage cocktail compr...</td>\n",
              "      <td>2023-08-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2023-12-31</td>\n",
              "      <td>2023</td>\n",
              "      <td>Phase 2</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: Randomized; Intervention Model: Pa...</td>\n",
              "      <td>Diabetic Foot Infection</td>\n",
              "      <td>Not yet recruiting</td>\n",
              "      <td>80</td>\n",
              "      <td>TP-102 (Biological), Placebo (Other)</td>\n",
              "      <td>All</td>\n",
              "      <td>18 Years - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Jose David Suarez</td>\n",
              "      <td>Technophage, SA; VectorB2B</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05948592</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Emerging Infectious Diseases; Clinical Researc...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>5.1 Pharmaceuticals; 6.1 Pharmaceuticals; 6.2 ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>764</td>\n",
              "      <td>NCT05973721</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>Clinical Study of Phage Therapy for Chronic Co...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The overall aim was to evaluate the efficacy o...</td>\n",
              "      <td>2023-07-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2023-10-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Pib Specific Phage; Intractable Constipation</td>\n",
              "      <td>Recruiting</td>\n",
              "      <td>50</td>\n",
              "      <td>phage (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>18 Years - 70 Years</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Hongliang Tian</td>\n",
              "      <td>Shanghai 10th People's Hospital; Shanghai Tent...</td>\n",
              "      <td>; grid.412538.9</td>\n",
              "      <td>; Shanghai</td>\n",
              "      <td>;</td>\n",
              "      <td>; China</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05973721</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>32 Biomedical and Clinical Sciences; 3202 Clin...</td>\n",
              "      <td>Digestive Diseases</td>\n",
              "      <td>NaN</td>\n",
              "      <td>5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>622</td>\n",
              "      <td>NCT05967130</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>Treatment Chronic UTI Post Kidney Transplant</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Urinary tract infections (UTIs) with extended-...</td>\n",
              "      <td>2023-07-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2024-07-01</td>\n",
              "      <td>2024</td>\n",
              "      <td>Phase 3</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Urinary Tract Infections; Transplant-Related D...</td>\n",
              "      <td>Recruiting</td>\n",
              "      <td>20</td>\n",
              "      <td>Phage (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>N/A - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Dalili</td>\n",
              "      <td>Shahid Beheshti University of Medical Sciences...</td>\n",
              "      <td>grid.411600.2;</td>\n",
              "      <td>Tehran; Tehran</td>\n",
              "      <td>;</td>\n",
              "      <td>Iran; Iran, Islamic Republic of</td>\n",
              "      <td>Shahid Beheshti University of Medical Sciences</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Iran</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05967130</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Urologic Diseases; Infectious Diseases; Transp...</td>\n",
              "      <td>Renal and urogenital; Infection</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>195</td>\n",
              "      <td>ISRCTN18158855</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>Evaluating the performance of blood-based test...</td>\n",
              "      <td>PHAGE-TB</td>\n",
              "      <td>Background and study aims \\nTuberculosis (TB) ...</td>\n",
              "      <td>2023-05-05</td>\n",
              "      <td>2023</td>\n",
              "      <td>2024-07-30</td>\n",
              "      <td>2024</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Observational</td>\n",
              "      <td>Allocation: Cohort Study; Primary Purpose: Dia...</td>\n",
              "      <td>Diagnosis of active tuberculosis disease</td>\n",
              "      <td>NaN</td>\n",
              "      <td>103</td>\n",
              "      <td>NaN</td>\n",
              "      <td>All</td>\n",
              "      <td>None - None</td>\n",
              "      <td>ISRCTN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>University of Leicester; PBD Biotech Limited; ...</td>\n",
              "      <td>grid.9918.9; ; grid.269014.8</td>\n",
              "      <td>Leicester; ; Leicester</td>\n",
              "      <td>; ;</td>\n",
              "      <td>United Kingdom; ; United Kingdom</td>\n",
              "      <td>University of Leicester</td>\n",
              "      <td>NaN</td>\n",
              "      <td>United Kingdom</td>\n",
              "      <td>https://www.isrctn.com/ISRCTN18158855</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>4203 Health Services and Systems; 32 Biomedica...</td>\n",
              "      <td>Biodefense; Clinical Research; Infectious Dise...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>4.2 Evaluation of markers and technologies; 4....</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>1042</td>\n",
              "      <td>NCT05537519</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>This is a single-patient, phase I/II clinical ...</td>\n",
              "      <td>2023-05-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2025-12-30</td>\n",
              "      <td>2025</td>\n",
              "      <td>Phase 1/2</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Recurrent Urinary Tract Infection</td>\n",
              "      <td>Active, not recruiting</td>\n",
              "      <td>1</td>\n",
              "      <td>Phage Therapy (Biological)</td>\n",
              "      <td>Female</td>\n",
              "      <td>18 Years - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Gregory German</td>\n",
              "      <td>Unity Health Toronto; Applied Health Research ...</td>\n",
              "      <td>; ; grid.416449.a</td>\n",
              "      <td>; ; Toronto</td>\n",
              "      <td>; ; Ontario</td>\n",
              "      <td>; ; Canada</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05537519</td>\n",
              "      <td>247</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>3207 Medical Microbiology; 32 Biomedical and C...</td>\n",
              "      <td>Infectious Diseases; Clinical Research; Urolog...</td>\n",
              "      <td>Infection; Renal and urogenital</td>\n",
              "      <td>6.1 Pharmaceuticals; 5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-90578f25-823c-481a-93d8-b1940a909434')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-90578f25-823c-481a-93d8-b1940a909434 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-90578f25-823c-481a-93d8-b1940a909434');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-026a21d3-4aee-487c-8230-03ac45dc0b87\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-026a21d3-4aee-487c-8230-03ac45dc0b87')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-026a21d3-4aee-487c-8230-03ac45dc0b87 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 5
        }
      ],
      "source": [
        "df = pd.read_excel ('/content/drive/MyDrive/YORKU PROJECT/JUDE/BACTERIOPHAGE/Dimensions-Clinical-Trial-2023-10-13_19-06-05.xlsx')#.drop(0)\n",
        "pd.set_option('display.max_columns', None)\n",
        "\n",
        "\n",
        "# Set the first row as the header\n",
        "df.columns = df.iloc[0]\n",
        "df = df.drop(df.index[0])\n",
        "\n",
        "print(len(df))\n",
        "df.head()"
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "JGLZ9VZyD5Uj"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "YpTWqFHW87lx"
      },
      "outputs": [],
      "source": [
        "# Replace NaN values with empty strings\n",
        "df['Title'].fillna(\"\", inplace=True)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "d_mfX0WF87oi"
      },
      "outputs": [],
      "source": [
        "# Replace NaN values with empty strings\n",
        "df['Brief title'].fillna(\"\", inplace=True)"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Replace NaN values with empty strings\n",
        "df['Abstract'].fillna(\"\", inplace=True)"
      ],
      "metadata": {
        "id": "pqIc3mfCEupL"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "benthWF0898u"
      },
      "outputs": [],
      "source": [
        "df['Title_Abstract'] = df['Title'] + \" \" + df['Brief title'] + \" \" + df['Abstract']"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "4iUS7nzNZPJ5",
        "outputId": "c5772483-96d3-46a9-9191-2a0213685f8d"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "0    Rank        Trial ID                                              Title  \\\n",
              "1     675     NCT05948592  A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2     764     NCT05973721  To Investigate the Clinical Efficacy and Safet...   \n",
              "3     622     NCT05967130  Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4     195  ISRCTN18158855  Evaluating the diagnostic utility of Actiphage...   \n",
              "5    1042     NCT05537519  Phage Therapy for the Treatment of Urinary Tra...   \n",
              "..    ...             ...                                                ...   \n",
              "105   407     NCT00001540  The Use of Bacteriophage Phi X174 to Assess th...   \n",
              "106   877     NCT04636554  Expanded Access Study of Phage Treatment in Co...   \n",
              "107   479     NCT03395769  Expanded Access Program for AB-SA01, an Invest...   \n",
              "108   479     NCT03395743  Expanded Access Program for AB-PA01, an Invest...   \n",
              "109   322     NCT00006066  Phase I/II Trial of Subcutaneous IL-2 With Hig...   \n",
              "\n",
              "0                                          Brief title   Acronym  \\\n",
              "1    Bacteriophage Therapy TP-102 in Patients With ...  REVERSE2   \n",
              "2    Clinical Study of Phage Therapy for Chronic Co...       NaN   \n",
              "3         Treatment Chronic UTI Post Kidney Transplant       NaN   \n",
              "4    Evaluating the performance of blood-based test...  PHAGE-TB   \n",
              "5    Phage Therapy for the Treatment of Urinary Tra...       NaN   \n",
              "..                                                 ...       ...   \n",
              "105  The Use of Bacteriophage Phi X174 to Assess th...       NaN   \n",
              "106  Personalized Phage Treatment in Covid-19 Patie...       NaN   \n",
              "107  Individual Patient Expanded Access for AB-SA01...       NaN   \n",
              "108  Individual Patient Expanded Access for AB-PA01...       NaN   \n",
              "109  Interleukin-2 Plus Anti-HIV Therapy in HIV-Inf...       NaN   \n",
              "\n",
              "0                                             Abstract  Start date Start Year  \\\n",
              "1    TP-102 is a novel bacteriophage cocktail compr...  2023-08-01       2023   \n",
              "2    The overall aim was to evaluate the efficacy o...  2023-07-01       2023   \n",
              "3    Urinary tract infections (UTIs) with extended-...  2023-07-01       2023   \n",
              "4    Background and study aims \\nTuberculosis (TB) ...  2023-05-05       2023   \n",
              "5    This is a single-patient, phase I/II clinical ...  2023-05-01       2023   \n",
              "..                                                 ...         ...        ...   \n",
              "105  The objective of this study is to evaluate the...  1996-04-01       1996   \n",
              "106  Phage Treatment in Covid-19 Patients with Bact...         NaN        NaN   \n",
              "107  The purpose of the expanded access program is ...         NaN        NaN   \n",
              "108  The purpose of the expanded access program is ...         NaN        NaN   \n",
              "109  The purpose of this study is to determine the ...         NaN        NaN   \n",
              "\n",
              "0      End Date Completion Year      Phase       Study Type  \\\n",
              "1    2023-12-31            2023    Phase 2   Interventional   \n",
              "2    2023-10-01            2023        NaN   Interventional   \n",
              "3    2024-07-01            2024    Phase 3   Interventional   \n",
              "4    2024-07-30            2024        NaN    Observational   \n",
              "5    2025-12-30            2025  Phase 1/2   Interventional   \n",
              "..          ...             ...        ...              ...   \n",
              "105  2000-03-01            2000        NaN    Observational   \n",
              "106         NaN             NaN        NaN  Expanded access   \n",
              "107         NaN             NaN        NaN  Expanded access   \n",
              "108         NaN             NaN        NaN  Expanded access   \n",
              "109  2006-06-01            2006    Phase 1   Interventional   \n",
              "\n",
              "0                                         Study Design  \\\n",
              "1    Allocation: Randomized; Intervention Model: Pa...   \n",
              "2    Allocation: N/A; Intervention Model: Single Gr...   \n",
              "3    Allocation: N/A; Intervention Model: Single Gr...   \n",
              "4    Allocation: Cohort Study; Primary Purpose: Dia...   \n",
              "5    Allocation: N/A; Intervention Model: Single Gr...   \n",
              "..                                                 ...   \n",
              "105                                                NaN   \n",
              "106                                                NaN   \n",
              "107                                                NaN   \n",
              "108                                                NaN   \n",
              "109                         Primary Purpose: Treatment   \n",
              "\n",
              "0                                           Conditions  \\\n",
              "1                              Diabetic Foot Infection   \n",
              "2         Pib Specific Phage; Intractable Constipation   \n",
              "3    Urinary Tract Infections; Transplant-Related D...   \n",
              "4             Diagnosis of active tuberculosis disease   \n",
              "5                    Recurrent Urinary Tract Infection   \n",
              "..                                                 ...   \n",
              "105                                     HIV Infections   \n",
              "106  Covid19; Bacteremia; Septicemia; Acinetobacter...   \n",
              "107                                                NaN   \n",
              "108                                                NaN   \n",
              "109                                     HIV Infections   \n",
              "\n",
              "0        Recruitment Status Number of Participants  \\\n",
              "1        Not yet recruiting                     80   \n",
              "2                Recruiting                     50   \n",
              "3                Recruiting                     20   \n",
              "4                       NaN                    103   \n",
              "5    Active, not recruiting                      1   \n",
              "..                      ...                    ...   \n",
              "105               Completed                     52   \n",
              "106     No longer available                    NaN   \n",
              "107     No longer available                    NaN   \n",
              "108     No longer available                    NaN   \n",
              "109               Completed                     92   \n",
              "\n",
              "0                                         Intervention  Gender  \\\n",
              "1                 TP-102 (Biological), Placebo (Other)     All   \n",
              "2                                   phage (Biological)     All   \n",
              "3                                   Phage (Biological)     All   \n",
              "4                                                  NaN     All   \n",
              "5                           Phage Therapy (Biological)  Female   \n",
              "..                                                 ...     ...   \n",
              "105                                                NaN     All   \n",
              "106                              Phage Therapy (Other)     All   \n",
              "107                               AB-SA01 (Biological)     All   \n",
              "108                               AB-PA01 (Biological)     All   \n",
              "109  Diphtheria & Tetanus Toxoids & Acellular Pertu...     All   \n",
              "\n",
              "0                    Age            Registry Investigators/Contacts  \\\n",
              "1         18 Years - N/A  ClinicalTrials.gov      Jose David Suarez   \n",
              "2    18 Years - 70 Years  ClinicalTrials.gov         Hongliang Tian   \n",
              "3              N/A - N/A  ClinicalTrials.gov                 Dalili   \n",
              "4            None - None              ISRCTN                    NaN   \n",
              "5         18 Years - N/A  ClinicalTrials.gov         Gregory German   \n",
              "..                   ...                 ...                    ...   \n",
              "105            N/A - N/A  ClinicalTrials.gov                    NaN   \n",
              "106       18 Years - N/A  ClinicalTrials.gov                    NaN   \n",
              "107            N/A - N/A  ClinicalTrials.gov                    NaN   \n",
              "108            N/A - N/A  ClinicalTrials.gov                    NaN   \n",
              "109   2 Years - 18 Years  ClinicalTrials.gov           Savita Pahwa   \n",
              "\n",
              "0                               Sponsors/Collaborators  \\\n",
              "1                           Technophage, SA; VectorB2B   \n",
              "2    Shanghai 10th People's Hospital; Shanghai Tent...   \n",
              "3    Shahid Beheshti University of Medical Sciences...   \n",
              "4    University of Leicester; PBD Biotech Limited; ...   \n",
              "5    Unity Health Toronto; Applied Health Research ...   \n",
              "..                                                 ...   \n",
              "105  National Institute of Allergy and Infectious D...   \n",
              "106                  Adaptive Phage Therapeutics, Inc.   \n",
              "107             Armata Pharmaceuticals (United States)   \n",
              "108             Armata Pharmaceuticals (United States)   \n",
              "109  National Institute of Allergy and Infectious D...   \n",
              "\n",
              "0                                             GRID IDs  \\\n",
              "1                                                   ;    \n",
              "2                                      ; grid.412538.9   \n",
              "3                                      grid.411600.2;    \n",
              "4                         grid.9918.9; ; grid.269014.8   \n",
              "5                                    ; ; grid.416449.a   \n",
              "..                                                 ...   \n",
              "105                       grid.419681.3; grid.419681.3   \n",
              "106                                                NaN   \n",
              "107                                      grid.515996.7   \n",
              "108                                      grid.515996.7   \n",
              "109  grid.419681.3; grid.420089.7; grid.415317.5; ;...   \n",
              "\n",
              "0                         City of Sponsor/Collaborator  \\\n",
              "1                                                   ;    \n",
              "2                                           ; Shanghai   \n",
              "3                                       Tehran; Tehran   \n",
              "4                               Leicester; ; Leicester   \n",
              "5                                          ; ; Toronto   \n",
              "..                                                 ...   \n",
              "105                                 Bethesda; Bethesda   \n",
              "106                                                NaN   \n",
              "107                                     Marina del Rey   \n",
              "108                                     Marina del Rey   \n",
              "109  Bethesda; Bethesda; Long Beach; Los Angeles; S...   \n",
              "\n",
              "0                        State of Sponsor/Collaborator  \\\n",
              "1                                                   ;    \n",
              "2                                                   ;    \n",
              "3                                                   ;    \n",
              "4                                                 ; ;    \n",
              "5                                          ; ; Ontario   \n",
              "..                                                 ...   \n",
              "105                                 Maryland; Maryland   \n",
              "106                                                NaN   \n",
              "107                                         California   \n",
              "108                                         California   \n",
              "109  Maryland; Maryland; California; California; Ca...   \n",
              "\n",
              "0                      Country of Sponsor/Collaborator  \\\n",
              "1                                                   ;    \n",
              "2                                              ; China   \n",
              "3                      Iran; Iran, Islamic Republic of   \n",
              "4                     United Kingdom; ; United Kingdom   \n",
              "5                                           ; ; Canada   \n",
              "..                                                 ...   \n",
              "105                       United States; United States   \n",
              "106                                                NaN   \n",
              "107                                      United States   \n",
              "108                                      United States   \n",
              "109  United States; United States; United States; U...   \n",
              "\n",
              "0                                Collaborating Funders  \\\n",
              "1                                                  NaN   \n",
              "2                                                  NaN   \n",
              "3       Shahid Beheshti University of Medical Sciences   \n",
              "4                              University of Leicester   \n",
              "5                                                  NaN   \n",
              "..                                                 ...   \n",
              "105  National Institute of Allergy and Infectious D...   \n",
              "106                                                NaN   \n",
              "107                                                NaN   \n",
              "108                                                NaN   \n",
              "109  Eunice Kennedy Shriver National Institute of C...   \n",
              "\n",
              "0                                         Funder Group  \\\n",
              "1                                                  NaN   \n",
              "2                                                  NaN   \n",
              "3                                                  NaN   \n",
              "4                                                  NaN   \n",
              "5                                                  NaN   \n",
              "..                                                 ...   \n",
              "105  US Federal Funders; NIH - National Institutes ...   \n",
              "106                                                NaN   \n",
              "107                                                NaN   \n",
              "108                                                NaN   \n",
              "109  US Federal Funders; NIH - National Institutes ...   \n",
              "\n",
              "0                  Funder Country  \\\n",
              "1                             NaN   \n",
              "2                             NaN   \n",
              "3                            Iran   \n",
              "4                  United Kingdom   \n",
              "5                             NaN   \n",
              "..                            ...   \n",
              "105                 United States   \n",
              "106                           NaN   \n",
              "107                           NaN   \n",
              "108                           NaN   \n",
              "109  United States; United States   \n",
              "\n",
              "0                                 Source Linkout Altmetric Attention Score  \\\n",
              "1    https://clinicaltrials.gov/show/NCT05948592                       NaN   \n",
              "2    https://clinicaltrials.gov/show/NCT05973721                       NaN   \n",
              "3    https://clinicaltrials.gov/show/NCT05967130                       NaN   \n",
              "4          https://www.isrctn.com/ISRCTN18158855                       NaN   \n",
              "5    https://clinicaltrials.gov/show/NCT05537519                       247   \n",
              "..                                           ...                       ...   \n",
              "105  https://clinicaltrials.gov/show/NCT00001540                       NaN   \n",
              "106  https://clinicaltrials.gov/show/NCT04636554                       NaN   \n",
              "107  https://clinicaltrials.gov/show/NCT03395769                       NaN   \n",
              "108  https://clinicaltrials.gov/show/NCT03395743                       NaN   \n",
              "109  https://clinicaltrials.gov/show/NCT00006066                       NaN   \n",
              "\n",
              "0                                       Dimensions URL  \\\n",
              "1    https://app.dimensions.ai/details/clinical_tri...   \n",
              "2    https://app.dimensions.ai/details/clinical_tri...   \n",
              "3    https://app.dimensions.ai/details/clinical_tri...   \n",
              "4    https://app.dimensions.ai/details/clinical_tri...   \n",
              "5    https://app.dimensions.ai/details/clinical_tri...   \n",
              "..                                                 ...   \n",
              "105  https://app.dimensions.ai/details/clinical_tri...   \n",
              "106  https://app.dimensions.ai/details/clinical_tri...   \n",
              "107  https://app.dimensions.ai/details/clinical_tri...   \n",
              "108  https://app.dimensions.ai/details/clinical_tri...   \n",
              "109  https://app.dimensions.ai/details/clinical_tri...   \n",
              "\n",
              "0                     Fields of Research (ANZSRC 2020)  \\\n",
              "1    31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "2    32 Biomedical and Clinical Sciences; 3202 Clin...   \n",
              "3    31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "4    4203 Health Services and Systems; 32 Biomedica...   \n",
              "5    3207 Medical Microbiology; 32 Biomedical and C...   \n",
              "..                                                 ...   \n",
              "105  3207 Medical Microbiology; 32 Biomedical and C...   \n",
              "106  31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "107  31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "108  3207 Medical Microbiology; 32 Biomedical and C...   \n",
              "109  3207 Medical Microbiology; 32 Biomedical and C...   \n",
              "\n",
              "0                                      RCDC Categories  \\\n",
              "1    Emerging Infectious Diseases; Clinical Researc...   \n",
              "2                                   Digestive Diseases   \n",
              "3    Urologic Diseases; Infectious Diseases; Transp...   \n",
              "4    Biodefense; Clinical Research; Infectious Dise...   \n",
              "5    Infectious Diseases; Clinical Research; Urolog...   \n",
              "..                                                 ...   \n",
              "105  Infectious Diseases; Clinical Trials and Suppo...   \n",
              "106  Pneumonia; Antimicrobial Resistance; Hematolog...   \n",
              "107  Emerging Infectious Diseases; Infectious Diseases   \n",
              "108                 Infectious Diseases; Rare Diseases   \n",
              "109  HIV/AIDS; Infectious Diseases; Pediatric AIDS;...   \n",
              "\n",
              "0                 HRCS HC Categories  \\\n",
              "1                          Infection   \n",
              "2                                NaN   \n",
              "3    Renal and urogenital; Infection   \n",
              "4                          Infection   \n",
              "5    Infection; Renal and urogenital   \n",
              "..                               ...   \n",
              "105                        Infection   \n",
              "106                        Infection   \n",
              "107                              NaN   \n",
              "108                              NaN   \n",
              "109                        Infection   \n",
              "\n",
              "0                                  HRCS RAC Categories Cancer Types  \\\n",
              "1    5.1 Pharmaceuticals; 6.1 Pharmaceuticals; 6.2 ...          NaN   \n",
              "2                                  5.1 Pharmaceuticals          NaN   \n",
              "3                                                  NaN          NaN   \n",
              "4    4.2 Evaluation of markers and technologies; 4....          NaN   \n",
              "5             6.1 Pharmaceuticals; 5.1 Pharmaceuticals          NaN   \n",
              "..                                                 ...          ...   \n",
              "105                                6.1 Pharmaceuticals          NaN   \n",
              "106                                5.1 Pharmaceuticals          NaN   \n",
              "107                                5.1 Pharmaceuticals          NaN   \n",
              "108                                                NaN          NaN   \n",
              "109           6.1 Pharmaceuticals; 5.1 Pharmaceuticals          NaN   \n",
              "\n",
              "0   CSO Categories                                     Title_Abstract  \\\n",
              "1              NaN  A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2              NaN  To Investigate the Clinical Efficacy and Safet...   \n",
              "3              NaN  Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4              NaN  Evaluating the diagnostic utility of Actiphage...   \n",
              "5              NaN  Phage Therapy for the Treatment of Urinary Tra...   \n",
              "..             ...                                                ...   \n",
              "105            NaN  The Use of Bacteriophage Phi X174 to Assess th...   \n",
              "106            NaN  Expanded Access Study of Phage Treatment in Co...   \n",
              "107            NaN  Expanded Access Program for AB-SA01, an Invest...   \n",
              "108            NaN  Expanded Access Program for AB-PA01, an Invest...   \n",
              "109            NaN  Phase I/II Trial of Subcutaneous IL-2 With Hig...   \n",
              "\n",
              "0                                  Title_Abstract_punc  \\\n",
              "1    A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2    To Investigate the Clinical Efficacy and Safet...   \n",
              "3    Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4    Evaluating the diagnostic utility of Actiphage...   \n",
              "5    Phage Therapy for the Treatment of Urinary Tra...   \n",
              "..                                                 ...   \n",
              "105  The Use of Bacteriophage Phi X174 to Assess th...   \n",
              "106  Expanded Access Study of Phage Treatment in Co...   \n",
              "107  Expanded Access Program for AB SA01  an Invest...   \n",
              "108  Expanded Access Program for AB PA01  an Invest...   \n",
              "109  Phase I II Trial of Subcutaneous IL 2 With Hig...   \n",
              "\n",
              "0                            Title_Abstract_punc_lower  \\\n",
              "1    a phase 2 ct to evaluate the safety and effica...   \n",
              "2    to investigate the clinical efficacy and safet...   \n",
              "3    treatment of chronic relapsing urinary tract i...   \n",
              "4    evaluating the diagnostic utility of actiphage...   \n",
              "5    phage therapy for the treatment of urinary tra...   \n",
              "..                                                 ...   \n",
              "105  the use of bacteriophage phi x174 to assess th...   \n",
              "106  expanded access study of phage treatment in co...   \n",
              "107  expanded access program for ab sa01  an invest...   \n",
              "108  expanded access program for ab pa01  an invest...   \n",
              "109  phase i ii trial of subcutaneous il 2 with hig...   \n",
              "\n",
              "0                                 Title_Abstract_lower  \\\n",
              "1    a phase 2 ct to evaluate the safety and effica...   \n",
              "2    to investigate the clinical efficacy and safet...   \n",
              "3    treatment of chronic relapsing urinary tract i...   \n",
              "4    evaluating the diagnostic utility of actiphage...   \n",
              "5    phage therapy for the treatment of urinary tra...   \n",
              "..                                                 ...   \n",
              "105  the use of bacteriophage phi x174 to assess th...   \n",
              "106  expanded access study of phage treatment in co...   \n",
              "107  expanded access program for ab-sa01, an invest...   \n",
              "108  expanded access program for ab-pa01, an invest...   \n",
              "109  phase i/ii trial of subcutaneous il-2 with hig...   \n",
              "\n",
              "0                                 Title_Abstract_upper  \\\n",
              "1    A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...   \n",
              "2    TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...   \n",
              "3    TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...   \n",
              "4    EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...   \n",
              "5    PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...   \n",
              "..                                                 ...   \n",
              "105  THE USE OF BACTERIOPHAGE PHI X174 TO ASSESS TH...   \n",
              "106  EXPANDED ACCESS STUDY OF PHAGE TREATMENT IN CO...   \n",
              "107  EXPANDED ACCESS PROGRAM FOR AB-SA01, AN INVEST...   \n",
              "108  EXPANDED ACCESS PROGRAM FOR AB-PA01, AN INVEST...   \n",
              "109  PHASE I/II TRIAL OF SUBCUTANEOUS IL-2 WITH HIG...   \n",
              "\n",
              "0                            Title_Abstract_punc_upper  \\\n",
              "1    A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...   \n",
              "2    TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...   \n",
              "3    TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...   \n",
              "4    EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...   \n",
              "5    PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...   \n",
              "..                                                 ...   \n",
              "105  THE USE OF BACTERIOPHAGE PHI X174 TO ASSESS TH...   \n",
              "106  EXPANDED ACCESS STUDY OF PHAGE TREATMENT IN CO...   \n",
              "107  EXPANDED ACCESS PROGRAM FOR AB SA01  AN INVEST...   \n",
              "108  EXPANDED ACCESS PROGRAM FOR AB PA01  AN INVEST...   \n",
              "109  PHASE I II TRIAL OF SUBCUTANEOUS IL 2 WITH HIG...   \n",
              "\n",
              "0                                Title_Abstract_concat  \n",
              "1    A Phase 2 CT to Evaluate the Safety and Effica...  \n",
              "2    To Investigate the Clinical Efficacy and Safet...  \n",
              "3    Treatment of Chronic Relapsing Urinary Tract I...  \n",
              "4    Evaluating the diagnostic utility of Actiphage...  \n",
              "5    Phage Therapy for the Treatment of Urinary Tra...  \n",
              "..                                                 ...  \n",
              "105  The Use of Bacteriophage Phi X174 to Assess th...  \n",
              "106  Expanded Access Study of Phage Treatment in Co...  \n",
              "107  Expanded Access Program for AB-SA01, an Invest...  \n",
              "108  Expanded Access Program for AB-PA01, an Invest...  \n",
              "109  Phase I/II Trial of Subcutaneous IL-2 With Hig...  \n",
              "\n",
              "[109 rows x 45 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-de5c54f7-3490-42df-bf2f-b18ef2e6b468\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Rank</th>\n",
              "      <th>Trial ID</th>\n",
              "      <th>Title</th>\n",
              "      <th>Brief title</th>\n",
              "      <th>Acronym</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Start date</th>\n",
              "      <th>Start Year</th>\n",
              "      <th>End Date</th>\n",
              "      <th>Completion Year</th>\n",
              "      <th>Phase</th>\n",
              "      <th>Study Type</th>\n",
              "      <th>Study Design</th>\n",
              "      <th>Conditions</th>\n",
              "      <th>Recruitment Status</th>\n",
              "      <th>Number of Participants</th>\n",
              "      <th>Intervention</th>\n",
              "      <th>Gender</th>\n",
              "      <th>Age</th>\n",
              "      <th>Registry</th>\n",
              "      <th>Investigators/Contacts</th>\n",
              "      <th>Sponsors/Collaborators</th>\n",
              "      <th>GRID IDs</th>\n",
              "      <th>City of Sponsor/Collaborator</th>\n",
              "      <th>State of Sponsor/Collaborator</th>\n",
              "      <th>Country of Sponsor/Collaborator</th>\n",
              "      <th>Collaborating Funders</th>\n",
              "      <th>Funder Group</th>\n",
              "      <th>Funder Country</th>\n",
              "      <th>Source Linkout</th>\n",
              "      <th>Altmetric Attention Score</th>\n",
              "      <th>Dimensions URL</th>\n",
              "      <th>Fields of Research (ANZSRC 2020)</th>\n",
              "      <th>RCDC Categories</th>\n",
              "      <th>HRCS HC Categories</th>\n",
              "      <th>HRCS RAC Categories</th>\n",
              "      <th>Cancer Types</th>\n",
              "      <th>CSO Categories</th>\n",
              "      <th>Title_Abstract</th>\n",
              "      <th>Title_Abstract_punc</th>\n",
              "      <th>Title_Abstract_punc_lower</th>\n",
              "      <th>Title_Abstract_lower</th>\n",
              "      <th>Title_Abstract_upper</th>\n",
              "      <th>Title_Abstract_punc_upper</th>\n",
              "      <th>Title_Abstract_concat</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>675</td>\n",
              "      <td>NCT05948592</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>Bacteriophage Therapy TP-102 in Patients With ...</td>\n",
              "      <td>REVERSE2</td>\n",
              "      <td>TP-102 is a novel bacteriophage cocktail compr...</td>\n",
              "      <td>2023-08-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2023-12-31</td>\n",
              "      <td>2023</td>\n",
              "      <td>Phase 2</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: Randomized; Intervention Model: Pa...</td>\n",
              "      <td>Diabetic Foot Infection</td>\n",
              "      <td>Not yet recruiting</td>\n",
              "      <td>80</td>\n",
              "      <td>TP-102 (Biological), Placebo (Other)</td>\n",
              "      <td>All</td>\n",
              "      <td>18 Years - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Jose David Suarez</td>\n",
              "      <td>Technophage, SA; VectorB2B</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05948592</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Emerging Infectious Diseases; Clinical Researc...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>5.1 Pharmaceuticals; 6.1 Pharmaceuticals; 6.2 ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>a phase 2 ct to evaluate the safety and effica...</td>\n",
              "      <td>a phase 2 ct to evaluate the safety and effica...</td>\n",
              "      <td>A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...</td>\n",
              "      <td>A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>764</td>\n",
              "      <td>NCT05973721</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>Clinical Study of Phage Therapy for Chronic Co...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The overall aim was to evaluate the efficacy o...</td>\n",
              "      <td>2023-07-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2023-10-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Pib Specific Phage; Intractable Constipation</td>\n",
              "      <td>Recruiting</td>\n",
              "      <td>50</td>\n",
              "      <td>phage (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>18 Years - 70 Years</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Hongliang Tian</td>\n",
              "      <td>Shanghai 10th People's Hospital; Shanghai Tent...</td>\n",
              "      <td>; grid.412538.9</td>\n",
              "      <td>; Shanghai</td>\n",
              "      <td>;</td>\n",
              "      <td>; China</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05973721</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>32 Biomedical and Clinical Sciences; 3202 Clin...</td>\n",
              "      <td>Digestive Diseases</td>\n",
              "      <td>NaN</td>\n",
              "      <td>5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>to investigate the clinical efficacy and safet...</td>\n",
              "      <td>to investigate the clinical efficacy and safet...</td>\n",
              "      <td>TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...</td>\n",
              "      <td>TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>622</td>\n",
              "      <td>NCT05967130</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>Treatment Chronic UTI Post Kidney Transplant</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Urinary tract infections (UTIs) with extended-...</td>\n",
              "      <td>2023-07-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2024-07-01</td>\n",
              "      <td>2024</td>\n",
              "      <td>Phase 3</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Urinary Tract Infections; Transplant-Related D...</td>\n",
              "      <td>Recruiting</td>\n",
              "      <td>20</td>\n",
              "      <td>Phage (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>N/A - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Dalili</td>\n",
              "      <td>Shahid Beheshti University of Medical Sciences...</td>\n",
              "      <td>grid.411600.2;</td>\n",
              "      <td>Tehran; Tehran</td>\n",
              "      <td>;</td>\n",
              "      <td>Iran; Iran, Islamic Republic of</td>\n",
              "      <td>Shahid Beheshti University of Medical Sciences</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Iran</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05967130</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Urologic Diseases; Infectious Diseases; Transp...</td>\n",
              "      <td>Renal and urogenital; Infection</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>treatment of chronic relapsing urinary tract i...</td>\n",
              "      <td>treatment of chronic relapsing urinary tract i...</td>\n",
              "      <td>TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...</td>\n",
              "      <td>TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>195</td>\n",
              "      <td>ISRCTN18158855</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>Evaluating the performance of blood-based test...</td>\n",
              "      <td>PHAGE-TB</td>\n",
              "      <td>Background and study aims \\nTuberculosis (TB) ...</td>\n",
              "      <td>2023-05-05</td>\n",
              "      <td>2023</td>\n",
              "      <td>2024-07-30</td>\n",
              "      <td>2024</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Observational</td>\n",
              "      <td>Allocation: Cohort Study; Primary Purpose: Dia...</td>\n",
              "      <td>Diagnosis of active tuberculosis disease</td>\n",
              "      <td>NaN</td>\n",
              "      <td>103</td>\n",
              "      <td>NaN</td>\n",
              "      <td>All</td>\n",
              "      <td>None - None</td>\n",
              "      <td>ISRCTN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>University of Leicester; PBD Biotech Limited; ...</td>\n",
              "      <td>grid.9918.9; ; grid.269014.8</td>\n",
              "      <td>Leicester; ; Leicester</td>\n",
              "      <td>; ;</td>\n",
              "      <td>United Kingdom; ; United Kingdom</td>\n",
              "      <td>University of Leicester</td>\n",
              "      <td>NaN</td>\n",
              "      <td>United Kingdom</td>\n",
              "      <td>https://www.isrctn.com/ISRCTN18158855</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>4203 Health Services and Systems; 32 Biomedica...</td>\n",
              "      <td>Biodefense; Clinical Research; Infectious Dise...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>4.2 Evaluation of markers and technologies; 4....</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>evaluating the diagnostic utility of actiphage...</td>\n",
              "      <td>evaluating the diagnostic utility of actiphage...</td>\n",
              "      <td>EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...</td>\n",
              "      <td>EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>1042</td>\n",
              "      <td>NCT05537519</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>This is a single-patient, phase I/II clinical ...</td>\n",
              "      <td>2023-05-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2025-12-30</td>\n",
              "      <td>2025</td>\n",
              "      <td>Phase 1/2</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Recurrent Urinary Tract Infection</td>\n",
              "      <td>Active, not recruiting</td>\n",
              "      <td>1</td>\n",
              "      <td>Phage Therapy (Biological)</td>\n",
              "      <td>Female</td>\n",
              "      <td>18 Years - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Gregory German</td>\n",
              "      <td>Unity Health Toronto; Applied Health Research ...</td>\n",
              "      <td>; ; grid.416449.a</td>\n",
              "      <td>; ; Toronto</td>\n",
              "      <td>; ; Ontario</td>\n",
              "      <td>; ; Canada</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05537519</td>\n",
              "      <td>247</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>3207 Medical Microbiology; 32 Biomedical and C...</td>\n",
              "      <td>Infectious Diseases; Clinical Research; Urolog...</td>\n",
              "      <td>Infection; Renal and urogenital</td>\n",
              "      <td>6.1 Pharmaceuticals; 5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>phage therapy for the treatment of urinary tra...</td>\n",
              "      <td>phage therapy for the treatment of urinary tra...</td>\n",
              "      <td>PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...</td>\n",
              "      <td>PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>105</th>\n",
              "      <td>407</td>\n",
              "      <td>NCT00001540</td>\n",
              "      <td>The Use of Bacteriophage Phi X174 to Assess th...</td>\n",
              "      <td>The Use of Bacteriophage Phi X174 to Assess th...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The objective of this study is to evaluate the...</td>\n",
              "      <td>1996-04-01</td>\n",
              "      <td>1996</td>\n",
              "      <td>2000-03-01</td>\n",
              "      <td>2000</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Observational</td>\n",
              "      <td>NaN</td>\n",
              "      <td>HIV Infections</td>\n",
              "      <td>Completed</td>\n",
              "      <td>52</td>\n",
              "      <td>NaN</td>\n",
              "      <td>All</td>\n",
              "      <td>N/A - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>NaN</td>\n",
              "      <td>National Institute of Allergy and Infectious D...</td>\n",
              "      <td>grid.419681.3; grid.419681.3</td>\n",
              "      <td>Bethesda; Bethesda</td>\n",
              "      <td>Maryland; Maryland</td>\n",
              "      <td>United States; United States</td>\n",
              "      <td>National Institute of Allergy and Infectious D...</td>\n",
              "      <td>US Federal Funders; NIH - National Institutes ...</td>\n",
              "      <td>United States</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT00001540</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>3207 Medical Microbiology; 32 Biomedical and C...</td>\n",
              "      <td>Infectious Diseases; Clinical Trials and Suppo...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>6.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The Use of Bacteriophage Phi X174 to Assess th...</td>\n",
              "      <td>The Use of Bacteriophage Phi X174 to Assess th...</td>\n",
              "      <td>the use of bacteriophage phi x174 to assess th...</td>\n",
              "      <td>the use of bacteriophage phi x174 to assess th...</td>\n",
              "      <td>THE USE OF BACTERIOPHAGE PHI X174 TO ASSESS TH...</td>\n",
              "      <td>THE USE OF BACTERIOPHAGE PHI X174 TO ASSESS TH...</td>\n",
              "      <td>The Use of Bacteriophage Phi X174 to Assess th...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>106</th>\n",
              "      <td>877</td>\n",
              "      <td>NCT04636554</td>\n",
              "      <td>Expanded Access Study of Phage Treatment in Co...</td>\n",
              "      <td>Personalized Phage Treatment in Covid-19 Patie...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Phage Treatment in Covid-19 Patients with Bact...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Expanded access</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Covid19; Bacteremia; Septicemia; Acinetobacter...</td>\n",
              "      <td>No longer available</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Phage Therapy (Other)</td>\n",
              "      <td>All</td>\n",
              "      <td>18 Years - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Adaptive Phage Therapeutics, Inc.</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT04636554</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Pneumonia; Antimicrobial Resistance; Hematolog...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Expanded Access Study of Phage Treatment in Co...</td>\n",
              "      <td>Expanded Access Study of Phage Treatment in Co...</td>\n",
              "      <td>expanded access study of phage treatment in co...</td>\n",
              "      <td>expanded access study of phage treatment in co...</td>\n",
              "      <td>EXPANDED ACCESS STUDY OF PHAGE TREATMENT IN CO...</td>\n",
              "      <td>EXPANDED ACCESS STUDY OF PHAGE TREATMENT IN CO...</td>\n",
              "      <td>Expanded Access Study of Phage Treatment in Co...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>107</th>\n",
              "      <td>479</td>\n",
              "      <td>NCT03395769</td>\n",
              "      <td>Expanded Access Program for AB-SA01, an Invest...</td>\n",
              "      <td>Individual Patient Expanded Access for AB-SA01...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The purpose of the expanded access program is ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Expanded access</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>No longer available</td>\n",
              "      <td>NaN</td>\n",
              "      <td>AB-SA01 (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>N/A - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Armata Pharmaceuticals (United States)</td>\n",
              "      <td>grid.515996.7</td>\n",
              "      <td>Marina del Rey</td>\n",
              "      <td>California</td>\n",
              "      <td>United States</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT03395769</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Emerging Infectious Diseases; Infectious Diseases</td>\n",
              "      <td>NaN</td>\n",
              "      <td>5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Expanded Access Program for AB-SA01, an Invest...</td>\n",
              "      <td>Expanded Access Program for AB SA01  an Invest...</td>\n",
              "      <td>expanded access program for ab sa01  an invest...</td>\n",
              "      <td>expanded access program for ab-sa01, an invest...</td>\n",
              "      <td>EXPANDED ACCESS PROGRAM FOR AB-SA01, AN INVEST...</td>\n",
              "      <td>EXPANDED ACCESS PROGRAM FOR AB SA01  AN INVEST...</td>\n",
              "      <td>Expanded Access Program for AB-SA01, an Invest...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>108</th>\n",
              "      <td>479</td>\n",
              "      <td>NCT03395743</td>\n",
              "      <td>Expanded Access Program for AB-PA01, an Invest...</td>\n",
              "      <td>Individual Patient Expanded Access for AB-PA01...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The purpose of the expanded access program is ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Expanded access</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>No longer available</td>\n",
              "      <td>NaN</td>\n",
              "      <td>AB-PA01 (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>N/A - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Armata Pharmaceuticals (United States)</td>\n",
              "      <td>grid.515996.7</td>\n",
              "      <td>Marina del Rey</td>\n",
              "      <td>California</td>\n",
              "      <td>United States</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT03395743</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>3207 Medical Microbiology; 32 Biomedical and C...</td>\n",
              "      <td>Infectious Diseases; Rare Diseases</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Expanded Access Program for AB-PA01, an Invest...</td>\n",
              "      <td>Expanded Access Program for AB PA01  an Invest...</td>\n",
              "      <td>expanded access program for ab pa01  an invest...</td>\n",
              "      <td>expanded access program for ab-pa01, an invest...</td>\n",
              "      <td>EXPANDED ACCESS PROGRAM FOR AB-PA01, AN INVEST...</td>\n",
              "      <td>EXPANDED ACCESS PROGRAM FOR AB PA01  AN INVEST...</td>\n",
              "      <td>Expanded Access Program for AB-PA01, an Invest...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>109</th>\n",
              "      <td>322</td>\n",
              "      <td>NCT00006066</td>\n",
              "      <td>Phase I/II Trial of Subcutaneous IL-2 With Hig...</td>\n",
              "      <td>Interleukin-2 Plus Anti-HIV Therapy in HIV-Inf...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The purpose of this study is to determine the ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2006-06-01</td>\n",
              "      <td>2006</td>\n",
              "      <td>Phase 1</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Primary Purpose: Treatment</td>\n",
              "      <td>HIV Infections</td>\n",
              "      <td>Completed</td>\n",
              "      <td>92</td>\n",
              "      <td>Diphtheria &amp; Tetanus Toxoids &amp; Acellular Pertu...</td>\n",
              "      <td>All</td>\n",
              "      <td>2 Years - 18 Years</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Savita Pahwa</td>\n",
              "      <td>National Institute of Allergy and Infectious D...</td>\n",
              "      <td>grid.419681.3; grid.420089.7; grid.415317.5; ;...</td>\n",
              "      <td>Bethesda; Bethesda; Long Beach; Los Angeles; S...</td>\n",
              "      <td>Maryland; Maryland; California; California; Ca...</td>\n",
              "      <td>United States; United States; United States; U...</td>\n",
              "      <td>Eunice Kennedy Shriver National Institute of C...</td>\n",
              "      <td>US Federal Funders; NIH - National Institutes ...</td>\n",
              "      <td>United States; United States</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT00006066</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>3207 Medical Microbiology; 32 Biomedical and C...</td>\n",
              "      <td>HIV/AIDS; Infectious Diseases; Pediatric AIDS;...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>6.1 Pharmaceuticals; 5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Phase I/II Trial of Subcutaneous IL-2 With Hig...</td>\n",
              "      <td>Phase I II Trial of Subcutaneous IL 2 With Hig...</td>\n",
              "      <td>phase i ii trial of subcutaneous il 2 with hig...</td>\n",
              "      <td>phase i/ii trial of subcutaneous il-2 with hig...</td>\n",
              "      <td>PHASE I/II TRIAL OF SUBCUTANEOUS IL-2 WITH HIG...</td>\n",
              "      <td>PHASE I II TRIAL OF SUBCUTANEOUS IL 2 WITH HIG...</td>\n",
              "      <td>Phase I/II Trial of Subcutaneous IL-2 With Hig...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>109 rows  45 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-de5c54f7-3490-42df-bf2f-b18ef2e6b468')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-de5c54f7-3490-42df-bf2f-b18ef2e6b468 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-de5c54f7-3490-42df-bf2f-b18ef2e6b468');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-d603cbc1-99f3-42be-9189-635a644f3b5a\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-d603cbc1-99f3-42be-9189-635a644f3b5a')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-d603cbc1-99f3-42be-9189-635a644f3b5a button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 10
        }
      ],
      "source": [
        "import pandas as pd\n",
        "import string\n",
        "\n",
        "# 2. Define a regular expression pattern for all punctuation\n",
        "pattern = '[{}]'.format(string.punctuation)\n",
        "\n",
        "# 3. Remove punctuation from column 'A'\n",
        "df['Title_Abstract_punc'] = df['Title_Abstract'].str.replace(pattern, ' ', regex=True)\n",
        "\n",
        "# 3. Remove punctuation from column 'A'\n",
        "df['Title_Abstract_punc_lower'] = df['Title_Abstract_punc'].str.lower()\n",
        "\n",
        "# 3. Remove punctuation from column 'A'\n",
        "df['Title_Abstract_lower'] = df['Title_Abstract'].str.lower()\n",
        "\n",
        "# 3. Remove punctuation from column 'A'\n",
        "df['Title_Abstract_upper'] = df['Title_Abstract'].str.upper()\n",
        "\n",
        "# 3. Remove punctuation from column 'A'\n",
        "df['Title_Abstract_punc_upper'] = df['Title_Abstract_punc'].str.upper()\n",
        "\n",
        "\n",
        "df['Title_Abstract_concat'] = df['Title_Abstract'] + \" \" + df['Title_Abstract_punc'] + \" \" + df['Title_Abstract_lower']  + \" \" + df['Title_Abstract_upper']  + \" \" + df['Title_Abstract_punc_upper']  + \" \" + df['Title_Abstract_punc_lower']\n",
        "\n",
        "# 4. Display the updated DataFrame\n",
        "df\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "VVmCVmQMhDju"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "M7wyP3IrhDnu"
      },
      "outputs": [],
      "source": [
        "#pip install spacy\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "SHlTdE5iZPdj",
        "outputId": "ff3c5cd0-0200-41de-e289-37791d3954d2"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "3.6.1\n"
          ]
        }
      ],
      "source": [
        "#import spacy\n",
        "print(spacy.__version__)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "WBPCsGRMKnto",
        "outputId": "fef5c5fb-1846-4a23-cedf-f44a02c4d357"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting scispacy\n",
            "  Downloading scispacy-0.5.3-py3-none-any.whl (45 kB)\n",
            "\u001b[?25l     \u001b[90m\u001b[0m \u001b[32m0.0/45.3 kB\u001b[0m \u001b[31m?\u001b[0m eta \u001b[36m-:--:--\u001b[0m\r\u001b[2K     \u001b[90m\u001b[0m \u001b[32m45.3/45.3 kB\u001b[0m \u001b[31m2.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: spacy<3.7.0,>=3.6.0 in /usr/local/lib/python3.10/dist-packages (from scispacy) (3.6.1)\n",
            "Collecting scipy<1.11 (from scispacy)\n",
            "  Downloading scipy-1.10.1-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (34.4 MB)\n",
            "\u001b[2K     \u001b[90m\u001b[0m \u001b[32m34.4/34.4 MB\u001b[0m \u001b[31m60.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: requests<3.0.0,>=2.0.0 in /usr/local/lib/python3.10/dist-packages (from scispacy) (2.31.0)\n",
            "Collecting conllu (from scispacy)\n",
            "  Downloading conllu-4.5.3-py2.py3-none-any.whl (16 kB)\n",
            "Requirement already satisfied: numpy in /usr/local/lib/python3.10/dist-packages (from scispacy) (1.23.5)\n",
            "Requirement already satisfied: joblib in /usr/local/lib/python3.10/dist-packages (from scispacy) (1.3.2)\n",
            "Collecting nmslib>=1.7.3.6 (from scispacy)\n",
            "  Downloading nmslib-2.1.1.tar.gz (188 kB)\n",
            "\u001b[2K     \u001b[90m\u001b[0m \u001b[32m188.7/188.7 kB\u001b[0m \u001b[31m18.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h  Preparing metadata (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "Requirement already satisfied: scikit-learn>=0.20.3 in /usr/local/lib/python3.10/dist-packages (from scispacy) (1.2.2)\n",
            "Collecting pysbd (from scispacy)\n",
            "  Downloading pysbd-0.3.4-py3-none-any.whl (71 kB)\n",
            "\u001b[2K     \u001b[90m\u001b[0m \u001b[32m71.1/71.1 kB\u001b[0m \u001b[31m11.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting pybind11<2.6.2 (from nmslib>=1.7.3.6->scispacy)\n",
            "  Using cached pybind11-2.6.1-py2.py3-none-any.whl (188 kB)\n",
            "Requirement already satisfied: psutil in /usr/local/lib/python3.10/dist-packages (from nmslib>=1.7.3.6->scispacy) (5.9.5)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.0.0->scispacy) (3.3.0)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.0.0->scispacy) (3.4)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.0.0->scispacy) (2.0.6)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.0.0->scispacy) (2023.7.22)\n",
            "Requirement already satisfied: threadpoolctl>=2.0.0 in /usr/local/lib/python3.10/dist-packages (from scikit-learn>=0.20.3->scispacy) (3.2.0)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.11 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (1.0.10)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (2.0.8)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (3.0.9)\n",
            "Requirement already satisfied: thinc<8.2.0,>=8.1.8 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (8.1.12)\n",
            "Requirement already satisfied: wasabi<1.2.0,>=0.9.1 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (1.1.2)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (2.4.8)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (2.0.10)\n",
            "Requirement already satisfied: typer<0.10.0,>=0.3.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (0.9.0)\n",
            "Requirement already satisfied: pathy>=0.10.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (0.10.2)\n",
            "Requirement already satisfied: smart-open<7.0.0,>=5.2.1 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (6.4.0)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (4.66.1)\n",
            "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (1.10.13)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (3.1.2)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (67.7.2)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (23.2)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.0->scispacy) (3.3.0)\n",
            "Requirement already satisfied: typing-extensions>=4.2.0 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.7.0,>=3.6.0->scispacy) (4.5.0)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.10/dist-packages (from thinc<8.2.0,>=8.1.8->spacy<3.7.0,>=3.6.0->scispacy) (0.7.11)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.10/dist-packages (from thinc<8.2.0,>=8.1.8->spacy<3.7.0,>=3.6.0->scispacy) (0.1.3)\n",
            "Requirement already satisfied: click<9.0.0,>=7.1.1 in /usr/local/lib/python3.10/dist-packages (from typer<0.10.0,>=0.3.0->spacy<3.7.0,>=3.6.0->scispacy) (8.1.7)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->spacy<3.7.0,>=3.6.0->scispacy) (2.1.3)\n",
            "Building wheels for collected packages: nmslib\n",
            "  Building wheel for nmslib (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "  Created wheel for nmslib: filename=nmslib-2.1.1-cp310-cp310-linux_x86_64.whl size=13544175 sha256=db45c78ce360424fe3af9f11fafa74456eedff1f9e25fad50127ca721833b8aa\n",
            "  Stored in directory: /root/.cache/pip/wheels/21/1a/5d/4cc754a5b1a88405cad184b76f823897a63a8d19afcd4b9314\n",
            "Successfully built nmslib\n",
            "Installing collected packages: scipy, pysbd, pybind11, conllu, nmslib, scispacy\n",
            "  Attempting uninstall: scipy\n",
            "    Found existing installation: scipy 1.11.3\n",
            "    Uninstalling scipy-1.11.3:\n",
            "      Successfully uninstalled scipy-1.11.3\n",
            "Successfully installed conllu-4.5.3 nmslib-2.1.1 pybind11-2.6.1 pysbd-0.3.4 scipy-1.10.1 scispacy-0.5.3\n"
          ]
        }
      ],
      "source": [
        "pip install scispacy"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "6scSDO3s775a"
      },
      "outputs": [],
      "source": [
        "#pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.4.0/en_ner_bc5cdr_md-0.4.0.tar.gz\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "E5oe0jrMcrJU"
      },
      "outputs": [],
      "source": [
        "#pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.5.3/en_core_sci_lg-0.5.3.tar.gz"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "SQQcCj0Ld0e9",
        "outputId": "6893bb61-dfac-4f90-bdac-83968d04ab88"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.5.3/en_ner_bc5cdr_md-0.5.3.tar.gz\n",
            "  Downloading https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.5.3/en_ner_bc5cdr_md-0.5.3.tar.gz (119.8 MB)\n",
            "\u001b[2K     \u001b[90m\u001b[0m \u001b[32m119.8/119.8 MB\u001b[0m \u001b[31m4.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h  Preparing metadata (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "Requirement already satisfied: spacy<3.7.0,>=3.6.1 in /usr/local/lib/python3.10/dist-packages (from en-ner-bc5cdr-md==0.5.3) (3.6.1)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.11 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (1.0.10)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (2.0.8)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (3.0.9)\n",
            "Requirement already satisfied: thinc<8.2.0,>=8.1.8 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (8.1.12)\n",
            "Requirement already satisfied: wasabi<1.2.0,>=0.9.1 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (1.1.2)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (2.4.8)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (2.0.10)\n",
            "Requirement already satisfied: typer<0.10.0,>=0.3.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (0.9.0)\n",
            "Requirement already satisfied: pathy>=0.10.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (0.10.2)\n",
            "Requirement already satisfied: smart-open<7.0.0,>=5.2.1 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (6.4.0)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (4.66.1)\n",
            "Requirement already satisfied: numpy>=1.15.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (1.23.5)\n",
            "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (2.31.0)\n",
            "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (1.10.13)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (3.1.2)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (67.7.2)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (23.2)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (3.3.0)\n",
            "Requirement already satisfied: typing-extensions>=4.2.0 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (4.5.0)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (3.3.0)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (3.4)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (2.0.6)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (2023.7.22)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.10/dist-packages (from thinc<8.2.0,>=8.1.8->spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (0.7.11)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.10/dist-packages (from thinc<8.2.0,>=8.1.8->spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (0.1.3)\n",
            "Requirement already satisfied: click<9.0.0,>=7.1.1 in /usr/local/lib/python3.10/dist-packages (from typer<0.10.0,>=0.3.0->spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (8.1.7)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->spacy<3.7.0,>=3.6.1->en-ner-bc5cdr-md==0.5.3) (2.1.3)\n",
            "Building wheels for collected packages: en-ner-bc5cdr-md\n",
            "  Building wheel for en-ner-bc5cdr-md (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "  Created wheel for en-ner-bc5cdr-md: filename=en_ner_bc5cdr_md-0.5.3-py3-none-any.whl size=119790313 sha256=9cdb210dfe8c24028745587de8b560d6c293360c7df0f45adfd69819cc78b924\n",
            "  Stored in directory: /root/.cache/pip/wheels/14/f5/28/d5bb4d966a84523c9135ec2113fb756fcc3098929f841334c1\n",
            "Successfully built en-ner-bc5cdr-md\n",
            "Installing collected packages: en-ner-bc5cdr-md\n",
            "Successfully installed en-ner-bc5cdr-md-0.5.3\n"
          ]
        }
      ],
      "source": [
        "pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.5.3/en_ner_bc5cdr_md-0.5.3.tar.gz"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "4tPGOyP9eBp4"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ev1QGgr55yio",
        "outputId": "af7c790f-b00e-475d-ac8d-cdd2287846fc"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/spacy/language.py:2141: FutureWarning: Possible set union at position 6328\n",
            "  deserializers[\"tokenizer\"] = lambda p: self.tokenizer.from_disk(  # type: ignore[union-attr]\n"
          ]
        }
      ],
      "source": [
        "import spacy\n",
        "import scispacy\n",
        "\n",
        "# Load the scispaCy model\n",
        "nlp = spacy.load(\"en_ner_bc5cdr_md\")\n",
        "\n",
        "def extract_diseases(text):\n",
        "    doc = nlp(text)\n",
        "    diseases = [ent.text for ent in doc.ents if ent.label_ == \"DISEASE\"]\n",
        "    return diseases\n",
        "\n",
        "df['Diseases'] = df['Title_Abstract_concat'].apply(extract_diseases)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "GwWGy2-iYXEH"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "cyLRNAOE5ymS",
        "outputId": "c7c69e5e-af89-4199-f738-20292be306f8"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "1      A Phase 2 CT to Evaluate the Safety and Effica...\n",
              "2      To Investigate the Clinical Efficacy and Safet...\n",
              "3      Treatment of Chronic Relapsing Urinary Tract I...\n",
              "4      Evaluating the diagnostic utility of Actiphage...\n",
              "5      Phage Therapy for the Treatment of Urinary Tra...\n",
              "                             ...                        \n",
              "105    The Use of Bacteriophage Phi X174 to Assess th...\n",
              "106    Expanded Access Study of Phage Treatment in Co...\n",
              "107    Expanded Access Program for AB-SA01, an Invest...\n",
              "108    Expanded Access Program for AB-PA01, an Invest...\n",
              "109    Phase I/II Trial of Subcutaneous IL-2 With Hig...\n",
              "Name: Title_Abstract_concat, Length: 109, dtype: object"
            ]
          },
          "metadata": {},
          "execution_count": 18
        }
      ],
      "source": [
        "df['Title_Abstract_concat']"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ChIyi_nT5ypS",
        "outputId": "6a98cd12-8af9-4cf0-f4dd-cf482666f651"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "1      [Diabetic Foot Infection TP-102, aeruginosa, A...\n",
              "2      [Chronic Constipation, Chronic Constipation, c...\n",
              "3      [UTIs, UTIs, urinary tract infections, UTIs, U...\n",
              "4      [active pulmonary TB, tuberculosis, Tuberculos...\n",
              "5      [urinary tract infection, urinary tract infect...\n",
              "                             ...                        \n",
              "105    [HIV Infected, HIV Infected, HIV infected, HIV...\n",
              "106    [Pneumonia, Bacteremia/Septicemia, Aeruginosa,...\n",
              "107    [Staphylococcus aureus infections, aureus infe...\n",
              "108    [Aeruginosa, Aeruginosa, Aeruginosa, aeruginos...\n",
              "109    [HIV infection, HIV infection, HIV infection, ...\n",
              "Name: Diseases, Length: 109, dtype: object"
            ]
          },
          "metadata": {},
          "execution_count": 19
        }
      ],
      "source": [
        "df['Diseases']"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 677
        },
        "id": "XiFxz1ia5yss",
        "outputId": "dee35067-f255-468e-ce5a-77153695f0e8"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "0  Rank        Trial ID                                              Title  \\\n",
              "1   675     NCT05948592  A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2   764     NCT05973721  To Investigate the Clinical Efficacy and Safet...   \n",
              "3   622     NCT05967130  Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4   195  ISRCTN18158855  Evaluating the diagnostic utility of Actiphage...   \n",
              "5  1042     NCT05537519  Phage Therapy for the Treatment of Urinary Tra...   \n",
              "\n",
              "0                                        Brief title   Acronym  \\\n",
              "1  Bacteriophage Therapy TP-102 in Patients With ...  REVERSE2   \n",
              "2  Clinical Study of Phage Therapy for Chronic Co...       NaN   \n",
              "3       Treatment Chronic UTI Post Kidney Transplant       NaN   \n",
              "4  Evaluating the performance of blood-based test...  PHAGE-TB   \n",
              "5  Phage Therapy for the Treatment of Urinary Tra...       NaN   \n",
              "\n",
              "0                                           Abstract  Start date Start Year  \\\n",
              "1  TP-102 is a novel bacteriophage cocktail compr...  2023-08-01       2023   \n",
              "2  The overall aim was to evaluate the efficacy o...  2023-07-01       2023   \n",
              "3  Urinary tract infections (UTIs) with extended-...  2023-07-01       2023   \n",
              "4  Background and study aims \\nTuberculosis (TB) ...  2023-05-05       2023   \n",
              "5  This is a single-patient, phase I/II clinical ...  2023-05-01       2023   \n",
              "\n",
              "0    End Date Completion Year      Phase      Study Type  \\\n",
              "1  2023-12-31            2023    Phase 2  Interventional   \n",
              "2  2023-10-01            2023        NaN  Interventional   \n",
              "3  2024-07-01            2024    Phase 3  Interventional   \n",
              "4  2024-07-30            2024        NaN   Observational   \n",
              "5  2025-12-30            2025  Phase 1/2  Interventional   \n",
              "\n",
              "0                                       Study Design  \\\n",
              "1  Allocation: Randomized; Intervention Model: Pa...   \n",
              "2  Allocation: N/A; Intervention Model: Single Gr...   \n",
              "3  Allocation: N/A; Intervention Model: Single Gr...   \n",
              "4  Allocation: Cohort Study; Primary Purpose: Dia...   \n",
              "5  Allocation: N/A; Intervention Model: Single Gr...   \n",
              "\n",
              "0                                         Conditions      Recruitment Status  \\\n",
              "1                            Diabetic Foot Infection      Not yet recruiting   \n",
              "2       Pib Specific Phage; Intractable Constipation              Recruiting   \n",
              "3  Urinary Tract Infections; Transplant-Related D...              Recruiting   \n",
              "4           Diagnosis of active tuberculosis disease                     NaN   \n",
              "5                  Recurrent Urinary Tract Infection  Active, not recruiting   \n",
              "\n",
              "0 Number of Participants                          Intervention  Gender  \\\n",
              "1                     80  TP-102 (Biological), Placebo (Other)     All   \n",
              "2                     50                    phage (Biological)     All   \n",
              "3                     20                    Phage (Biological)     All   \n",
              "4                    103                                   NaN     All   \n",
              "5                      1            Phage Therapy (Biological)  Female   \n",
              "\n",
              "0                  Age            Registry Investigators/Contacts  \\\n",
              "1       18 Years - N/A  ClinicalTrials.gov      Jose David Suarez   \n",
              "2  18 Years - 70 Years  ClinicalTrials.gov         Hongliang Tian   \n",
              "3            N/A - N/A  ClinicalTrials.gov                 Dalili   \n",
              "4          None - None              ISRCTN                    NaN   \n",
              "5       18 Years - N/A  ClinicalTrials.gov         Gregory German   \n",
              "\n",
              "0                             Sponsors/Collaborators  \\\n",
              "1                         Technophage, SA; VectorB2B   \n",
              "2  Shanghai 10th People's Hospital; Shanghai Tent...   \n",
              "3  Shahid Beheshti University of Medical Sciences...   \n",
              "4  University of Leicester; PBD Biotech Limited; ...   \n",
              "5  Unity Health Toronto; Applied Health Research ...   \n",
              "\n",
              "0                      GRID IDs City of Sponsor/Collaborator  \\\n",
              "1                            ;                            ;    \n",
              "2               ; grid.412538.9                   ; Shanghai   \n",
              "3               grid.411600.2;                Tehran; Tehran   \n",
              "4  grid.9918.9; ; grid.269014.8       Leicester; ; Leicester   \n",
              "5             ; ; grid.416449.a                  ; ; Toronto   \n",
              "\n",
              "0 State of Sponsor/Collaborator   Country of Sponsor/Collaborator  \\\n",
              "1                            ;                                 ;    \n",
              "2                            ;                            ; China   \n",
              "3                            ;    Iran; Iran, Islamic Republic of   \n",
              "4                          ; ;   United Kingdom; ; United Kingdom   \n",
              "5                   ; ; Ontario                        ; ; Canada   \n",
              "\n",
              "0                           Collaborating Funders Funder Group  \\\n",
              "1                                             NaN          NaN   \n",
              "2                                             NaN          NaN   \n",
              "3  Shahid Beheshti University of Medical Sciences          NaN   \n",
              "4                         University of Leicester          NaN   \n",
              "5                                             NaN          NaN   \n",
              "\n",
              "0  Funder Country                               Source Linkout  \\\n",
              "1             NaN  https://clinicaltrials.gov/show/NCT05948592   \n",
              "2             NaN  https://clinicaltrials.gov/show/NCT05973721   \n",
              "3            Iran  https://clinicaltrials.gov/show/NCT05967130   \n",
              "4  United Kingdom        https://www.isrctn.com/ISRCTN18158855   \n",
              "5             NaN  https://clinicaltrials.gov/show/NCT05537519   \n",
              "\n",
              "0 Altmetric Attention Score  \\\n",
              "1                       NaN   \n",
              "2                       NaN   \n",
              "3                       NaN   \n",
              "4                       NaN   \n",
              "5                       247   \n",
              "\n",
              "0                                     Dimensions URL  \\\n",
              "1  https://app.dimensions.ai/details/clinical_tri...   \n",
              "2  https://app.dimensions.ai/details/clinical_tri...   \n",
              "3  https://app.dimensions.ai/details/clinical_tri...   \n",
              "4  https://app.dimensions.ai/details/clinical_tri...   \n",
              "5  https://app.dimensions.ai/details/clinical_tri...   \n",
              "\n",
              "0                   Fields of Research (ANZSRC 2020)  \\\n",
              "1  31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "2  32 Biomedical and Clinical Sciences; 3202 Clin...   \n",
              "3  31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "4  4203 Health Services and Systems; 32 Biomedica...   \n",
              "5  3207 Medical Microbiology; 32 Biomedical and C...   \n",
              "\n",
              "0                                    RCDC Categories  \\\n",
              "1  Emerging Infectious Diseases; Clinical Researc...   \n",
              "2                                 Digestive Diseases   \n",
              "3  Urologic Diseases; Infectious Diseases; Transp...   \n",
              "4  Biodefense; Clinical Research; Infectious Dise...   \n",
              "5  Infectious Diseases; Clinical Research; Urolog...   \n",
              "\n",
              "0               HRCS HC Categories  \\\n",
              "1                        Infection   \n",
              "2                              NaN   \n",
              "3  Renal and urogenital; Infection   \n",
              "4                        Infection   \n",
              "5  Infection; Renal and urogenital   \n",
              "\n",
              "0                                HRCS RAC Categories Cancer Types  \\\n",
              "1  5.1 Pharmaceuticals; 6.1 Pharmaceuticals; 6.2 ...          NaN   \n",
              "2                                5.1 Pharmaceuticals          NaN   \n",
              "3                                                NaN          NaN   \n",
              "4  4.2 Evaluation of markers and technologies; 4....          NaN   \n",
              "5           6.1 Pharmaceuticals; 5.1 Pharmaceuticals          NaN   \n",
              "\n",
              "0 CSO Categories                                     Title_Abstract  \\\n",
              "1            NaN  A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2            NaN  To Investigate the Clinical Efficacy and Safet...   \n",
              "3            NaN  Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4            NaN  Evaluating the diagnostic utility of Actiphage...   \n",
              "5            NaN  Phage Therapy for the Treatment of Urinary Tra...   \n",
              "\n",
              "0                                Title_Abstract_punc  \\\n",
              "1  A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2  To Investigate the Clinical Efficacy and Safet...   \n",
              "3  Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4  Evaluating the diagnostic utility of Actiphage...   \n",
              "5  Phage Therapy for the Treatment of Urinary Tra...   \n",
              "\n",
              "0                          Title_Abstract_punc_lower  \\\n",
              "1  a phase 2 ct to evaluate the safety and effica...   \n",
              "2  to investigate the clinical efficacy and safet...   \n",
              "3  treatment of chronic relapsing urinary tract i...   \n",
              "4  evaluating the diagnostic utility of actiphage...   \n",
              "5  phage therapy for the treatment of urinary tra...   \n",
              "\n",
              "0                               Title_Abstract_lower  \\\n",
              "1  a phase 2 ct to evaluate the safety and effica...   \n",
              "2  to investigate the clinical efficacy and safet...   \n",
              "3  treatment of chronic relapsing urinary tract i...   \n",
              "4  evaluating the diagnostic utility of actiphage...   \n",
              "5  phage therapy for the treatment of urinary tra...   \n",
              "\n",
              "0                               Title_Abstract_upper  \\\n",
              "1  A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...   \n",
              "2  TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...   \n",
              "3  TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...   \n",
              "4  EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...   \n",
              "5  PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...   \n",
              "\n",
              "0                          Title_Abstract_punc_upper  \\\n",
              "1  A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...   \n",
              "2  TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...   \n",
              "3  TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...   \n",
              "4  EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...   \n",
              "5  PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...   \n",
              "\n",
              "0                              Title_Abstract_concat  \\\n",
              "1  A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2  To Investigate the Clinical Efficacy and Safet...   \n",
              "3  Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4  Evaluating the diagnostic utility of Actiphage...   \n",
              "5  Phage Therapy for the Treatment of Urinary Tra...   \n",
              "\n",
              "0                                           Diseases  \n",
              "1  [Diabetic Foot Infection TP-102, aeruginosa, A...  \n",
              "2  [Chronic Constipation, Chronic Constipation, c...  \n",
              "3  [UTIs, UTIs, urinary tract infections, UTIs, U...  \n",
              "4  [active pulmonary TB, tuberculosis, Tuberculos...  \n",
              "5  [urinary tract infection, urinary tract infect...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-09370875-bb4a-469d-8eee-a4d697ff54d1\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Rank</th>\n",
              "      <th>Trial ID</th>\n",
              "      <th>Title</th>\n",
              "      <th>Brief title</th>\n",
              "      <th>Acronym</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Start date</th>\n",
              "      <th>Start Year</th>\n",
              "      <th>End Date</th>\n",
              "      <th>Completion Year</th>\n",
              "      <th>Phase</th>\n",
              "      <th>Study Type</th>\n",
              "      <th>Study Design</th>\n",
              "      <th>Conditions</th>\n",
              "      <th>Recruitment Status</th>\n",
              "      <th>Number of Participants</th>\n",
              "      <th>Intervention</th>\n",
              "      <th>Gender</th>\n",
              "      <th>Age</th>\n",
              "      <th>Registry</th>\n",
              "      <th>Investigators/Contacts</th>\n",
              "      <th>Sponsors/Collaborators</th>\n",
              "      <th>GRID IDs</th>\n",
              "      <th>City of Sponsor/Collaborator</th>\n",
              "      <th>State of Sponsor/Collaborator</th>\n",
              "      <th>Country of Sponsor/Collaborator</th>\n",
              "      <th>Collaborating Funders</th>\n",
              "      <th>Funder Group</th>\n",
              "      <th>Funder Country</th>\n",
              "      <th>Source Linkout</th>\n",
              "      <th>Altmetric Attention Score</th>\n",
              "      <th>Dimensions URL</th>\n",
              "      <th>Fields of Research (ANZSRC 2020)</th>\n",
              "      <th>RCDC Categories</th>\n",
              "      <th>HRCS HC Categories</th>\n",
              "      <th>HRCS RAC Categories</th>\n",
              "      <th>Cancer Types</th>\n",
              "      <th>CSO Categories</th>\n",
              "      <th>Title_Abstract</th>\n",
              "      <th>Title_Abstract_punc</th>\n",
              "      <th>Title_Abstract_punc_lower</th>\n",
              "      <th>Title_Abstract_lower</th>\n",
              "      <th>Title_Abstract_upper</th>\n",
              "      <th>Title_Abstract_punc_upper</th>\n",
              "      <th>Title_Abstract_concat</th>\n",
              "      <th>Diseases</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>675</td>\n",
              "      <td>NCT05948592</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>Bacteriophage Therapy TP-102 in Patients With ...</td>\n",
              "      <td>REVERSE2</td>\n",
              "      <td>TP-102 is a novel bacteriophage cocktail compr...</td>\n",
              "      <td>2023-08-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2023-12-31</td>\n",
              "      <td>2023</td>\n",
              "      <td>Phase 2</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: Randomized; Intervention Model: Pa...</td>\n",
              "      <td>Diabetic Foot Infection</td>\n",
              "      <td>Not yet recruiting</td>\n",
              "      <td>80</td>\n",
              "      <td>TP-102 (Biological), Placebo (Other)</td>\n",
              "      <td>All</td>\n",
              "      <td>18 Years - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Jose David Suarez</td>\n",
              "      <td>Technophage, SA; VectorB2B</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05948592</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Emerging Infectious Diseases; Clinical Researc...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>5.1 Pharmaceuticals; 6.1 Pharmaceuticals; 6.2 ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>a phase 2 ct to evaluate the safety and effica...</td>\n",
              "      <td>a phase 2 ct to evaluate the safety and effica...</td>\n",
              "      <td>A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...</td>\n",
              "      <td>A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>[Diabetic Foot Infection TP-102, aeruginosa, A...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>764</td>\n",
              "      <td>NCT05973721</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>Clinical Study of Phage Therapy for Chronic Co...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The overall aim was to evaluate the efficacy o...</td>\n",
              "      <td>2023-07-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2023-10-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Pib Specific Phage; Intractable Constipation</td>\n",
              "      <td>Recruiting</td>\n",
              "      <td>50</td>\n",
              "      <td>phage (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>18 Years - 70 Years</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Hongliang Tian</td>\n",
              "      <td>Shanghai 10th People's Hospital; Shanghai Tent...</td>\n",
              "      <td>; grid.412538.9</td>\n",
              "      <td>; Shanghai</td>\n",
              "      <td>;</td>\n",
              "      <td>; China</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05973721</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>32 Biomedical and Clinical Sciences; 3202 Clin...</td>\n",
              "      <td>Digestive Diseases</td>\n",
              "      <td>NaN</td>\n",
              "      <td>5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>to investigate the clinical efficacy and safet...</td>\n",
              "      <td>to investigate the clinical efficacy and safet...</td>\n",
              "      <td>TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...</td>\n",
              "      <td>TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>[Chronic Constipation, Chronic Constipation, c...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>622</td>\n",
              "      <td>NCT05967130</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>Treatment Chronic UTI Post Kidney Transplant</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Urinary tract infections (UTIs) with extended-...</td>\n",
              "      <td>2023-07-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2024-07-01</td>\n",
              "      <td>2024</td>\n",
              "      <td>Phase 3</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Urinary Tract Infections; Transplant-Related D...</td>\n",
              "      <td>Recruiting</td>\n",
              "      <td>20</td>\n",
              "      <td>Phage (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>N/A - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Dalili</td>\n",
              "      <td>Shahid Beheshti University of Medical Sciences...</td>\n",
              "      <td>grid.411600.2;</td>\n",
              "      <td>Tehran; Tehran</td>\n",
              "      <td>;</td>\n",
              "      <td>Iran; Iran, Islamic Republic of</td>\n",
              "      <td>Shahid Beheshti University of Medical Sciences</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Iran</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05967130</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Urologic Diseases; Infectious Diseases; Transp...</td>\n",
              "      <td>Renal and urogenital; Infection</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>treatment of chronic relapsing urinary tract i...</td>\n",
              "      <td>treatment of chronic relapsing urinary tract i...</td>\n",
              "      <td>TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...</td>\n",
              "      <td>TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>[UTIs, UTIs, urinary tract infections, UTIs, U...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>195</td>\n",
              "      <td>ISRCTN18158855</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>Evaluating the performance of blood-based test...</td>\n",
              "      <td>PHAGE-TB</td>\n",
              "      <td>Background and study aims \\nTuberculosis (TB) ...</td>\n",
              "      <td>2023-05-05</td>\n",
              "      <td>2023</td>\n",
              "      <td>2024-07-30</td>\n",
              "      <td>2024</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Observational</td>\n",
              "      <td>Allocation: Cohort Study; Primary Purpose: Dia...</td>\n",
              "      <td>Diagnosis of active tuberculosis disease</td>\n",
              "      <td>NaN</td>\n",
              "      <td>103</td>\n",
              "      <td>NaN</td>\n",
              "      <td>All</td>\n",
              "      <td>None - None</td>\n",
              "      <td>ISRCTN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>University of Leicester; PBD Biotech Limited; ...</td>\n",
              "      <td>grid.9918.9; ; grid.269014.8</td>\n",
              "      <td>Leicester; ; Leicester</td>\n",
              "      <td>; ;</td>\n",
              "      <td>United Kingdom; ; United Kingdom</td>\n",
              "      <td>University of Leicester</td>\n",
              "      <td>NaN</td>\n",
              "      <td>United Kingdom</td>\n",
              "      <td>https://www.isrctn.com/ISRCTN18158855</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>4203 Health Services and Systems; 32 Biomedica...</td>\n",
              "      <td>Biodefense; Clinical Research; Infectious Dise...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>4.2 Evaluation of markers and technologies; 4....</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>evaluating the diagnostic utility of actiphage...</td>\n",
              "      <td>evaluating the diagnostic utility of actiphage...</td>\n",
              "      <td>EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...</td>\n",
              "      <td>EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>[active pulmonary TB, tuberculosis, Tuberculos...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>1042</td>\n",
              "      <td>NCT05537519</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>This is a single-patient, phase I/II clinical ...</td>\n",
              "      <td>2023-05-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2025-12-30</td>\n",
              "      <td>2025</td>\n",
              "      <td>Phase 1/2</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Recurrent Urinary Tract Infection</td>\n",
              "      <td>Active, not recruiting</td>\n",
              "      <td>1</td>\n",
              "      <td>Phage Therapy (Biological)</td>\n",
              "      <td>Female</td>\n",
              "      <td>18 Years - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Gregory German</td>\n",
              "      <td>Unity Health Toronto; Applied Health Research ...</td>\n",
              "      <td>; ; grid.416449.a</td>\n",
              "      <td>; ; Toronto</td>\n",
              "      <td>; ; Ontario</td>\n",
              "      <td>; ; Canada</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05537519</td>\n",
              "      <td>247</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>3207 Medical Microbiology; 32 Biomedical and C...</td>\n",
              "      <td>Infectious Diseases; Clinical Research; Urolog...</td>\n",
              "      <td>Infection; Renal and urogenital</td>\n",
              "      <td>6.1 Pharmaceuticals; 5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>phage therapy for the treatment of urinary tra...</td>\n",
              "      <td>phage therapy for the treatment of urinary tra...</td>\n",
              "      <td>PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...</td>\n",
              "      <td>PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>[urinary tract infection, urinary tract infect...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-09370875-bb4a-469d-8eee-a4d697ff54d1')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-09370875-bb4a-469d-8eee-a4d697ff54d1 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-09370875-bb4a-469d-8eee-a4d697ff54d1');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-59ce9074-70ba-4a20-a0a1-43c1497f4aca\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-59ce9074-70ba-4a20-a0a1-43c1497f4aca')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-59ce9074-70ba-4a20-a0a1-43c1497f4aca button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 20
        }
      ],
      "source": [
        "import os\n",
        "# Create the directory if it doesn't exist\n",
        "output_directory = \"/content/drive/MyDrive/YORKU PROJECT/JUDE/BACTERIOPHAGE/clinicalTrial_phage_therapy_diseases_Taxon\"\n",
        "if not os.path.exists(output_directory):\n",
        "    os.makedirs(output_directory)\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "# Save data to CSV and Pickle formats\n",
        "df.to_csv(f'/content/drive/MyDrive/YORKU PROJECT/JUDE/BACTERIOPHAGE/clinicalTrial_phage_therapy_diseases_Taxon/clinicalTrial_phage_therapy_dimension_13102023_and_diseases.csv', index=False)\n",
        "df.to_pickle(f'/content/drive/MyDrive/YORKU PROJECT/JUDE/BACTERIOPHAGE/clinicalTrial_phage_therapy_diseases_Taxon/clinicalTrial_phage_therapy_dimension_13102023_and_diseases.pkl')\n",
        "\n",
        "df.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "WGMOyKbM5yvn"
      },
      "outputs": [],
      "source": [
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "W4WarEyx5yyd"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "SMAiE8qxIKQy",
        "outputId": "ac444f79-4633-4d68-f76e-dbadfd5a9dde"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.5.3/en_ner_bionlp13cg_md-0.5.3.tar.gz\n",
            "  Downloading https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.5.3/en_ner_bionlp13cg_md-0.5.3.tar.gz (119.8 MB)\n",
            "\u001b[2K     \u001b[90m\u001b[0m \u001b[32m119.8/119.8 MB\u001b[0m \u001b[31m3.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h  Preparing metadata (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "Requirement already satisfied: spacy<3.7.0,>=3.6.1 in /usr/local/lib/python3.10/dist-packages (from en-ner-bionlp13cg-md==0.5.3) (3.6.1)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.11 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (1.0.10)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (2.0.8)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (3.0.9)\n",
            "Requirement already satisfied: thinc<8.2.0,>=8.1.8 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (8.1.12)\n",
            "Requirement already satisfied: wasabi<1.2.0,>=0.9.1 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (1.1.2)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (2.4.8)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (2.0.10)\n",
            "Requirement already satisfied: typer<0.10.0,>=0.3.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (0.9.0)\n",
            "Requirement already satisfied: pathy>=0.10.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (0.10.2)\n",
            "Requirement already satisfied: smart-open<7.0.0,>=5.2.1 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (6.4.0)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (4.66.1)\n",
            "Requirement already satisfied: numpy>=1.15.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (1.23.5)\n",
            "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (2.31.0)\n",
            "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (1.10.13)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (3.1.2)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (67.7.2)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (23.2)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (3.3.0)\n",
            "Requirement already satisfied: typing-extensions>=4.2.0 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (4.5.0)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (3.3.0)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (3.4)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (2.0.6)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (2023.7.22)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.10/dist-packages (from thinc<8.2.0,>=8.1.8->spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (0.7.11)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.10/dist-packages (from thinc<8.2.0,>=8.1.8->spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (0.1.3)\n",
            "Requirement already satisfied: click<9.0.0,>=7.1.1 in /usr/local/lib/python3.10/dist-packages (from typer<0.10.0,>=0.3.0->spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (8.1.7)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->spacy<3.7.0,>=3.6.1->en-ner-bionlp13cg-md==0.5.3) (2.1.3)\n",
            "Building wheels for collected packages: en-ner-bionlp13cg-md\n",
            "  Building wheel for en-ner-bionlp13cg-md (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "  Created wheel for en-ner-bionlp13cg-md: filename=en_ner_bionlp13cg_md-0.5.3-py3-none-any.whl size=119816875 sha256=953623fc366c69138c89b503ef69c6dc2a5d54b32597c91730c8213c1ae61902\n",
            "  Stored in directory: /root/.cache/pip/wheels/57/41/8f/d3506513af9ed67b47f7caed69951922defb753cf3a9e4cbdb\n",
            "Successfully built en-ner-bionlp13cg-md\n",
            "Installing collected packages: en-ner-bionlp13cg-md\n",
            "Successfully installed en-ner-bionlp13cg-md-0.5.3\n"
          ]
        }
      ],
      "source": [
        "pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.5.3/en_ner_bionlp13cg_md-0.5.3.tar.gz"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "1sqLplpWIKTs"
      },
      "outputs": [],
      "source": [
        "import spacy\n",
        "\n",
        "# Load the scispaCy model\n",
        "nlp = spacy.load(\"en_ner_bionlp13cg_md\")\n",
        "\n",
        "def extract_microorganisms(text):\n",
        "    doc = nlp(text)\n",
        "    microorganisms = [ent.text for ent in doc.ents if ent.label_ == \"ORGANISM\"]\n",
        "    return microorganisms\n",
        "\n",
        "# Assuming df is your DataFrame with concatenated titles and abstracts\n",
        "df['Microorganisms'] = df['Title_Abstract_concat'].apply(extract_microorganisms)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "8CwAjtU6IKWG",
        "outputId": "2d8bdb6d-4972-450c-c326-6ff72c7b2064"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "1      [Patients, Patients, patients, patients, patie...\n",
              "2      [PiB-specific, patients, patients, patients, p...\n",
              "3      [Patients, patients, UTIs, cephalosporin-susce...\n",
              "4      [patients, participants, participants, People,...\n",
              "5      [bacteriophage, bacteriophage, patient, bacter...\n",
              "                             ...                        \n",
              "105    [Patients, Patients, bacteriophage phi X174, p...\n",
              "106    [A., patients, A., patients, A., A., Patients,...\n",
              "107    [Patient, patients, Patient, patients, patient...\n",
              "108    [Patients, Patient, patients, Patients, Patien...\n",
              "109    [Children, Children, children, People, people,...\n",
              "Name: Microorganisms, Length: 109, dtype: object"
            ]
          },
          "metadata": {},
          "execution_count": 23
        }
      ],
      "source": [
        "df['Microorganisms']"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 677
        },
        "id": "4ukrbXG3IKaD",
        "outputId": "cf7d9837-c0f2-4aa5-baa8-002957105738"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "0  Rank        Trial ID                                              Title  \\\n",
              "1   675     NCT05948592  A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2   764     NCT05973721  To Investigate the Clinical Efficacy and Safet...   \n",
              "3   622     NCT05967130  Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4   195  ISRCTN18158855  Evaluating the diagnostic utility of Actiphage...   \n",
              "5  1042     NCT05537519  Phage Therapy for the Treatment of Urinary Tra...   \n",
              "\n",
              "0                                        Brief title   Acronym  \\\n",
              "1  Bacteriophage Therapy TP-102 in Patients With ...  REVERSE2   \n",
              "2  Clinical Study of Phage Therapy for Chronic Co...       NaN   \n",
              "3       Treatment Chronic UTI Post Kidney Transplant       NaN   \n",
              "4  Evaluating the performance of blood-based test...  PHAGE-TB   \n",
              "5  Phage Therapy for the Treatment of Urinary Tra...       NaN   \n",
              "\n",
              "0                                           Abstract  Start date Start Year  \\\n",
              "1  TP-102 is a novel bacteriophage cocktail compr...  2023-08-01       2023   \n",
              "2  The overall aim was to evaluate the efficacy o...  2023-07-01       2023   \n",
              "3  Urinary tract infections (UTIs) with extended-...  2023-07-01       2023   \n",
              "4  Background and study aims \\nTuberculosis (TB) ...  2023-05-05       2023   \n",
              "5  This is a single-patient, phase I/II clinical ...  2023-05-01       2023   \n",
              "\n",
              "0    End Date Completion Year      Phase      Study Type  \\\n",
              "1  2023-12-31            2023    Phase 2  Interventional   \n",
              "2  2023-10-01            2023        NaN  Interventional   \n",
              "3  2024-07-01            2024    Phase 3  Interventional   \n",
              "4  2024-07-30            2024        NaN   Observational   \n",
              "5  2025-12-30            2025  Phase 1/2  Interventional   \n",
              "\n",
              "0                                       Study Design  \\\n",
              "1  Allocation: Randomized; Intervention Model: Pa...   \n",
              "2  Allocation: N/A; Intervention Model: Single Gr...   \n",
              "3  Allocation: N/A; Intervention Model: Single Gr...   \n",
              "4  Allocation: Cohort Study; Primary Purpose: Dia...   \n",
              "5  Allocation: N/A; Intervention Model: Single Gr...   \n",
              "\n",
              "0                                         Conditions      Recruitment Status  \\\n",
              "1                            Diabetic Foot Infection      Not yet recruiting   \n",
              "2       Pib Specific Phage; Intractable Constipation              Recruiting   \n",
              "3  Urinary Tract Infections; Transplant-Related D...              Recruiting   \n",
              "4           Diagnosis of active tuberculosis disease                     NaN   \n",
              "5                  Recurrent Urinary Tract Infection  Active, not recruiting   \n",
              "\n",
              "0 Number of Participants                          Intervention  Gender  \\\n",
              "1                     80  TP-102 (Biological), Placebo (Other)     All   \n",
              "2                     50                    phage (Biological)     All   \n",
              "3                     20                    Phage (Biological)     All   \n",
              "4                    103                                   NaN     All   \n",
              "5                      1            Phage Therapy (Biological)  Female   \n",
              "\n",
              "0                  Age            Registry Investigators/Contacts  \\\n",
              "1       18 Years - N/A  ClinicalTrials.gov      Jose David Suarez   \n",
              "2  18 Years - 70 Years  ClinicalTrials.gov         Hongliang Tian   \n",
              "3            N/A - N/A  ClinicalTrials.gov                 Dalili   \n",
              "4          None - None              ISRCTN                    NaN   \n",
              "5       18 Years - N/A  ClinicalTrials.gov         Gregory German   \n",
              "\n",
              "0                             Sponsors/Collaborators  \\\n",
              "1                         Technophage, SA; VectorB2B   \n",
              "2  Shanghai 10th People's Hospital; Shanghai Tent...   \n",
              "3  Shahid Beheshti University of Medical Sciences...   \n",
              "4  University of Leicester; PBD Biotech Limited; ...   \n",
              "5  Unity Health Toronto; Applied Health Research ...   \n",
              "\n",
              "0                      GRID IDs City of Sponsor/Collaborator  \\\n",
              "1                            ;                            ;    \n",
              "2               ; grid.412538.9                   ; Shanghai   \n",
              "3               grid.411600.2;                Tehran; Tehran   \n",
              "4  grid.9918.9; ; grid.269014.8       Leicester; ; Leicester   \n",
              "5             ; ; grid.416449.a                  ; ; Toronto   \n",
              "\n",
              "0 State of Sponsor/Collaborator   Country of Sponsor/Collaborator  \\\n",
              "1                            ;                                 ;    \n",
              "2                            ;                            ; China   \n",
              "3                            ;    Iran; Iran, Islamic Republic of   \n",
              "4                          ; ;   United Kingdom; ; United Kingdom   \n",
              "5                   ; ; Ontario                        ; ; Canada   \n",
              "\n",
              "0                           Collaborating Funders Funder Group  \\\n",
              "1                                             NaN          NaN   \n",
              "2                                             NaN          NaN   \n",
              "3  Shahid Beheshti University of Medical Sciences          NaN   \n",
              "4                         University of Leicester          NaN   \n",
              "5                                             NaN          NaN   \n",
              "\n",
              "0  Funder Country                               Source Linkout  \\\n",
              "1             NaN  https://clinicaltrials.gov/show/NCT05948592   \n",
              "2             NaN  https://clinicaltrials.gov/show/NCT05973721   \n",
              "3            Iran  https://clinicaltrials.gov/show/NCT05967130   \n",
              "4  United Kingdom        https://www.isrctn.com/ISRCTN18158855   \n",
              "5             NaN  https://clinicaltrials.gov/show/NCT05537519   \n",
              "\n",
              "0 Altmetric Attention Score  \\\n",
              "1                       NaN   \n",
              "2                       NaN   \n",
              "3                       NaN   \n",
              "4                       NaN   \n",
              "5                       247   \n",
              "\n",
              "0                                     Dimensions URL  \\\n",
              "1  https://app.dimensions.ai/details/clinical_tri...   \n",
              "2  https://app.dimensions.ai/details/clinical_tri...   \n",
              "3  https://app.dimensions.ai/details/clinical_tri...   \n",
              "4  https://app.dimensions.ai/details/clinical_tri...   \n",
              "5  https://app.dimensions.ai/details/clinical_tri...   \n",
              "\n",
              "0                   Fields of Research (ANZSRC 2020)  \\\n",
              "1  31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "2  32 Biomedical and Clinical Sciences; 3202 Clin...   \n",
              "3  31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "4  4203 Health Services and Systems; 32 Biomedica...   \n",
              "5  3207 Medical Microbiology; 32 Biomedical and C...   \n",
              "\n",
              "0                                    RCDC Categories  \\\n",
              "1  Emerging Infectious Diseases; Clinical Researc...   \n",
              "2                                 Digestive Diseases   \n",
              "3  Urologic Diseases; Infectious Diseases; Transp...   \n",
              "4  Biodefense; Clinical Research; Infectious Dise...   \n",
              "5  Infectious Diseases; Clinical Research; Urolog...   \n",
              "\n",
              "0               HRCS HC Categories  \\\n",
              "1                        Infection   \n",
              "2                              NaN   \n",
              "3  Renal and urogenital; Infection   \n",
              "4                        Infection   \n",
              "5  Infection; Renal and urogenital   \n",
              "\n",
              "0                                HRCS RAC Categories Cancer Types  \\\n",
              "1  5.1 Pharmaceuticals; 6.1 Pharmaceuticals; 6.2 ...          NaN   \n",
              "2                                5.1 Pharmaceuticals          NaN   \n",
              "3                                                NaN          NaN   \n",
              "4  4.2 Evaluation of markers and technologies; 4....          NaN   \n",
              "5           6.1 Pharmaceuticals; 5.1 Pharmaceuticals          NaN   \n",
              "\n",
              "0 CSO Categories                                     Title_Abstract  \\\n",
              "1            NaN  A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2            NaN  To Investigate the Clinical Efficacy and Safet...   \n",
              "3            NaN  Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4            NaN  Evaluating the diagnostic utility of Actiphage...   \n",
              "5            NaN  Phage Therapy for the Treatment of Urinary Tra...   \n",
              "\n",
              "0                                Title_Abstract_punc  \\\n",
              "1  A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2  To Investigate the Clinical Efficacy and Safet...   \n",
              "3  Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4  Evaluating the diagnostic utility of Actiphage...   \n",
              "5  Phage Therapy for the Treatment of Urinary Tra...   \n",
              "\n",
              "0                          Title_Abstract_punc_lower  \\\n",
              "1  a phase 2 ct to evaluate the safety and effica...   \n",
              "2  to investigate the clinical efficacy and safet...   \n",
              "3  treatment of chronic relapsing urinary tract i...   \n",
              "4  evaluating the diagnostic utility of actiphage...   \n",
              "5  phage therapy for the treatment of urinary tra...   \n",
              "\n",
              "0                               Title_Abstract_lower  \\\n",
              "1  a phase 2 ct to evaluate the safety and effica...   \n",
              "2  to investigate the clinical efficacy and safet...   \n",
              "3  treatment of chronic relapsing urinary tract i...   \n",
              "4  evaluating the diagnostic utility of actiphage...   \n",
              "5  phage therapy for the treatment of urinary tra...   \n",
              "\n",
              "0                               Title_Abstract_upper  \\\n",
              "1  A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...   \n",
              "2  TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...   \n",
              "3  TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...   \n",
              "4  EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...   \n",
              "5  PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...   \n",
              "\n",
              "0                          Title_Abstract_punc_upper  \\\n",
              "1  A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...   \n",
              "2  TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...   \n",
              "3  TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...   \n",
              "4  EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...   \n",
              "5  PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...   \n",
              "\n",
              "0                              Title_Abstract_concat  \\\n",
              "1  A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2  To Investigate the Clinical Efficacy and Safet...   \n",
              "3  Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4  Evaluating the diagnostic utility of Actiphage...   \n",
              "5  Phage Therapy for the Treatment of Urinary Tra...   \n",
              "\n",
              "0                                           Diseases  \\\n",
              "1  [Diabetic Foot Infection TP-102, aeruginosa, A...   \n",
              "2  [Chronic Constipation, Chronic Constipation, c...   \n",
              "3  [UTIs, UTIs, urinary tract infections, UTIs, U...   \n",
              "4  [active pulmonary TB, tuberculosis, Tuberculos...   \n",
              "5  [urinary tract infection, urinary tract infect...   \n",
              "\n",
              "0                                     Microorganisms  \n",
              "1  [Patients, Patients, patients, patients, patie...  \n",
              "2  [PiB-specific, patients, patients, patients, p...  \n",
              "3  [Patients, patients, UTIs, cephalosporin-susce...  \n",
              "4  [patients, participants, participants, People,...  \n",
              "5  [bacteriophage, bacteriophage, patient, bacter...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-2111da15-9d78-4874-a4f2-335cf982a96c\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Rank</th>\n",
              "      <th>Trial ID</th>\n",
              "      <th>Title</th>\n",
              "      <th>Brief title</th>\n",
              "      <th>Acronym</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Start date</th>\n",
              "      <th>Start Year</th>\n",
              "      <th>End Date</th>\n",
              "      <th>Completion Year</th>\n",
              "      <th>Phase</th>\n",
              "      <th>Study Type</th>\n",
              "      <th>Study Design</th>\n",
              "      <th>Conditions</th>\n",
              "      <th>Recruitment Status</th>\n",
              "      <th>Number of Participants</th>\n",
              "      <th>Intervention</th>\n",
              "      <th>Gender</th>\n",
              "      <th>Age</th>\n",
              "      <th>Registry</th>\n",
              "      <th>Investigators/Contacts</th>\n",
              "      <th>Sponsors/Collaborators</th>\n",
              "      <th>GRID IDs</th>\n",
              "      <th>City of Sponsor/Collaborator</th>\n",
              "      <th>State of Sponsor/Collaborator</th>\n",
              "      <th>Country of Sponsor/Collaborator</th>\n",
              "      <th>Collaborating Funders</th>\n",
              "      <th>Funder Group</th>\n",
              "      <th>Funder Country</th>\n",
              "      <th>Source Linkout</th>\n",
              "      <th>Altmetric Attention Score</th>\n",
              "      <th>Dimensions URL</th>\n",
              "      <th>Fields of Research (ANZSRC 2020)</th>\n",
              "      <th>RCDC Categories</th>\n",
              "      <th>HRCS HC Categories</th>\n",
              "      <th>HRCS RAC Categories</th>\n",
              "      <th>Cancer Types</th>\n",
              "      <th>CSO Categories</th>\n",
              "      <th>Title_Abstract</th>\n",
              "      <th>Title_Abstract_punc</th>\n",
              "      <th>Title_Abstract_punc_lower</th>\n",
              "      <th>Title_Abstract_lower</th>\n",
              "      <th>Title_Abstract_upper</th>\n",
              "      <th>Title_Abstract_punc_upper</th>\n",
              "      <th>Title_Abstract_concat</th>\n",
              "      <th>Diseases</th>\n",
              "      <th>Microorganisms</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>675</td>\n",
              "      <td>NCT05948592</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>Bacteriophage Therapy TP-102 in Patients With ...</td>\n",
              "      <td>REVERSE2</td>\n",
              "      <td>TP-102 is a novel bacteriophage cocktail compr...</td>\n",
              "      <td>2023-08-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2023-12-31</td>\n",
              "      <td>2023</td>\n",
              "      <td>Phase 2</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: Randomized; Intervention Model: Pa...</td>\n",
              "      <td>Diabetic Foot Infection</td>\n",
              "      <td>Not yet recruiting</td>\n",
              "      <td>80</td>\n",
              "      <td>TP-102 (Biological), Placebo (Other)</td>\n",
              "      <td>All</td>\n",
              "      <td>18 Years - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Jose David Suarez</td>\n",
              "      <td>Technophage, SA; VectorB2B</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05948592</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Emerging Infectious Diseases; Clinical Researc...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>5.1 Pharmaceuticals; 6.1 Pharmaceuticals; 6.2 ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>a phase 2 ct to evaluate the safety and effica...</td>\n",
              "      <td>a phase 2 ct to evaluate the safety and effica...</td>\n",
              "      <td>A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...</td>\n",
              "      <td>A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>[Diabetic Foot Infection TP-102, aeruginosa, A...</td>\n",
              "      <td>[Patients, Patients, patients, patients, patie...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>764</td>\n",
              "      <td>NCT05973721</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>Clinical Study of Phage Therapy for Chronic Co...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The overall aim was to evaluate the efficacy o...</td>\n",
              "      <td>2023-07-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2023-10-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Pib Specific Phage; Intractable Constipation</td>\n",
              "      <td>Recruiting</td>\n",
              "      <td>50</td>\n",
              "      <td>phage (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>18 Years - 70 Years</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Hongliang Tian</td>\n",
              "      <td>Shanghai 10th People's Hospital; Shanghai Tent...</td>\n",
              "      <td>; grid.412538.9</td>\n",
              "      <td>; Shanghai</td>\n",
              "      <td>;</td>\n",
              "      <td>; China</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05973721</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>32 Biomedical and Clinical Sciences; 3202 Clin...</td>\n",
              "      <td>Digestive Diseases</td>\n",
              "      <td>NaN</td>\n",
              "      <td>5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>to investigate the clinical efficacy and safet...</td>\n",
              "      <td>to investigate the clinical efficacy and safet...</td>\n",
              "      <td>TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...</td>\n",
              "      <td>TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>[Chronic Constipation, Chronic Constipation, c...</td>\n",
              "      <td>[PiB-specific, patients, patients, patients, p...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>622</td>\n",
              "      <td>NCT05967130</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>Treatment Chronic UTI Post Kidney Transplant</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Urinary tract infections (UTIs) with extended-...</td>\n",
              "      <td>2023-07-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2024-07-01</td>\n",
              "      <td>2024</td>\n",
              "      <td>Phase 3</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Urinary Tract Infections; Transplant-Related D...</td>\n",
              "      <td>Recruiting</td>\n",
              "      <td>20</td>\n",
              "      <td>Phage (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>N/A - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Dalili</td>\n",
              "      <td>Shahid Beheshti University of Medical Sciences...</td>\n",
              "      <td>grid.411600.2;</td>\n",
              "      <td>Tehran; Tehran</td>\n",
              "      <td>;</td>\n",
              "      <td>Iran; Iran, Islamic Republic of</td>\n",
              "      <td>Shahid Beheshti University of Medical Sciences</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Iran</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05967130</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Urologic Diseases; Infectious Diseases; Transp...</td>\n",
              "      <td>Renal and urogenital; Infection</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>treatment of chronic relapsing urinary tract i...</td>\n",
              "      <td>treatment of chronic relapsing urinary tract i...</td>\n",
              "      <td>TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...</td>\n",
              "      <td>TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>[UTIs, UTIs, urinary tract infections, UTIs, U...</td>\n",
              "      <td>[Patients, patients, UTIs, cephalosporin-susce...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>195</td>\n",
              "      <td>ISRCTN18158855</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>Evaluating the performance of blood-based test...</td>\n",
              "      <td>PHAGE-TB</td>\n",
              "      <td>Background and study aims \\nTuberculosis (TB) ...</td>\n",
              "      <td>2023-05-05</td>\n",
              "      <td>2023</td>\n",
              "      <td>2024-07-30</td>\n",
              "      <td>2024</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Observational</td>\n",
              "      <td>Allocation: Cohort Study; Primary Purpose: Dia...</td>\n",
              "      <td>Diagnosis of active tuberculosis disease</td>\n",
              "      <td>NaN</td>\n",
              "      <td>103</td>\n",
              "      <td>NaN</td>\n",
              "      <td>All</td>\n",
              "      <td>None - None</td>\n",
              "      <td>ISRCTN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>University of Leicester; PBD Biotech Limited; ...</td>\n",
              "      <td>grid.9918.9; ; grid.269014.8</td>\n",
              "      <td>Leicester; ; Leicester</td>\n",
              "      <td>; ;</td>\n",
              "      <td>United Kingdom; ; United Kingdom</td>\n",
              "      <td>University of Leicester</td>\n",
              "      <td>NaN</td>\n",
              "      <td>United Kingdom</td>\n",
              "      <td>https://www.isrctn.com/ISRCTN18158855</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>4203 Health Services and Systems; 32 Biomedica...</td>\n",
              "      <td>Biodefense; Clinical Research; Infectious Dise...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>4.2 Evaluation of markers and technologies; 4....</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>evaluating the diagnostic utility of actiphage...</td>\n",
              "      <td>evaluating the diagnostic utility of actiphage...</td>\n",
              "      <td>EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...</td>\n",
              "      <td>EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>[active pulmonary TB, tuberculosis, Tuberculos...</td>\n",
              "      <td>[patients, participants, participants, People,...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>1042</td>\n",
              "      <td>NCT05537519</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>This is a single-patient, phase I/II clinical ...</td>\n",
              "      <td>2023-05-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2025-12-30</td>\n",
              "      <td>2025</td>\n",
              "      <td>Phase 1/2</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Recurrent Urinary Tract Infection</td>\n",
              "      <td>Active, not recruiting</td>\n",
              "      <td>1</td>\n",
              "      <td>Phage Therapy (Biological)</td>\n",
              "      <td>Female</td>\n",
              "      <td>18 Years - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Gregory German</td>\n",
              "      <td>Unity Health Toronto; Applied Health Research ...</td>\n",
              "      <td>; ; grid.416449.a</td>\n",
              "      <td>; ; Toronto</td>\n",
              "      <td>; ; Ontario</td>\n",
              "      <td>; ; Canada</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05537519</td>\n",
              "      <td>247</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>3207 Medical Microbiology; 32 Biomedical and C...</td>\n",
              "      <td>Infectious Diseases; Clinical Research; Urolog...</td>\n",
              "      <td>Infection; Renal and urogenital</td>\n",
              "      <td>6.1 Pharmaceuticals; 5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>phage therapy for the treatment of urinary tra...</td>\n",
              "      <td>phage therapy for the treatment of urinary tra...</td>\n",
              "      <td>PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...</td>\n",
              "      <td>PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>[urinary tract infection, urinary tract infect...</td>\n",
              "      <td>[bacteriophage, bacteriophage, patient, bacter...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-2111da15-9d78-4874-a4f2-335cf982a96c')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-2111da15-9d78-4874-a4f2-335cf982a96c button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-2111da15-9d78-4874-a4f2-335cf982a96c');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-a2260d86-5e27-4b1c-a11d-6ac3585b2297\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-a2260d86-5e27-4b1c-a11d-6ac3585b2297')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-a2260d86-5e27-4b1c-a11d-6ac3585b2297 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 24
        }
      ],
      "source": [
        "# Save data to CSV and Pickle formats\n",
        "df.to_csv(f'/content/drive/MyDrive/YORKU PROJECT/JUDE/BACTERIOPHAGE/clinicalTrial_phage_therapy_diseases_Taxon/clinicalTrial_phage_therapy_dimension_13102023_and_diseases_Microorganisms.csv', index=False)\n",
        "df.to_pickle(f'/content/drive/MyDrive/YORKU PROJECT/JUDE/BACTERIOPHAGE/clinicalTrial_phage_therapy_diseases_Taxon/clinicalTrial_phage_therapy_dimension_13102023_and_diseases_Microorganisms.pkl')\n",
        "\n",
        "df.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "jPNiBjfXd_Qi",
        "outputId": "668db0d6-932a-429e-ee78-2b237982fb60"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "spatio temporal variation of the microbiome and resistome repertoire along an anthropogenically dynamic segment of the ganges river  india aquatic ecosystems are regarded as a hub of antibiotic and metal resistance genes  river ganges is a unique riverine system in india with socio cultural and economic significance  however  it remains underexplored for its microbiome and associated resistomes along its anthropogenically impacted course  the present study utilized a nanopore sequenc ing approach to depict the microbial community structure in the sediments of the river ganges harboring antibiotic and metal resistance genes  a mrgs  in lower stretches known for anthropogenic impact  comprehensive microbiome analyses revealed resistance genes against 23 different types of metals and 28 classes of antibiotics  the most dominant arg category was multidrug resistance  while the most prevalent mrgs conferred resistance against copper and zinc  seasonal differences dismally affected the microbiota of the ganges  however  resistance genes for fosmidomycin and tetracycline varied with season anova  p   0 05  interestingly  333 and 334 arg subtypes were observed at all the locations in pre monsoon and post monsoon  respectively  the taxa associated with the dominant args and mrgs were pseudomonas and burkholderia  which are important nosocomial pathogens  a substantial phage diversity for pathogenic and putrefying bacteria at all locations attracts attention for its use to tackle the dissemination of antibiotic and metal resistant bacteria  this study suggests the accumulation of antibiotics and metals as the driving force for the emergence of resistance genes and the affiliated bacteria trafficking them  the present metagenomic as sessment highlights the need for comprehensive  long term biological and physicochemical monitoring and mitigation strategies toward the contaminants associated with args and mrgs in this nationally important river  antibiotic resistance genes  heavy metals  water  downstream  sediments  reservoir  sludge river ganges  metagenomics  antibiotics  args   heavy metals  mrgs   microbiome  bacteriophages"
            ]
          },
          "metadata": {},
          "execution_count": 25
        }
      ],
      "source": [
        "nlp('spatio temporal variation of the microbiome and resistome repertoire along an anthropogenically dynamic segment of the ganges river  india aquatic ecosystems are regarded as a hub of antibiotic and metal resistance genes  river ganges is a unique riverine system in india with socio cultural and economic significance  however  it remains underexplored for its microbiome and associated resistomes along its anthropogenically impacted course  the present study utilized a nanopore sequenc ing approach to depict the microbial community structure in the sediments of the river ganges harboring antibiotic and metal resistance genes  a mrgs  in lower stretches known for anthropogenic impact  comprehensive microbiome analyses revealed resistance genes against 23 different types of metals and 28 classes of antibiotics  the most dominant arg category was multidrug resistance  while the most prevalent mrgs conferred resistance against copper and zinc  seasonal differences dismally affected the microbiota of the ganges  however  resistance genes for fosmidomycin and tetracycline varied with season anova  p   0 05  interestingly  333 and 334 arg subtypes were observed at all the locations in pre monsoon and post monsoon  respectively  the taxa associated with the dominant args and mrgs were pseudomonas and burkholderia  which are important nosocomial pathogens  a substantial phage diversity for pathogenic and putrefying bacteria at all locations attracts attention for its use to tackle the dissemination of antibiotic and metal resistant bacteria  this study suggests the accumulation of antibiotics and metals as the driving force for the emergence of resistance genes and the affiliated bacteria trafficking them  the present metagenomic as sessment highlights the need for comprehensive  long term biological and physicochemical monitoring and mitigation strategies toward the contaminants associated with args and mrgs in this nationally important river  antibiotic resistance genes  heavy metals  water  downstream  sediments  reservoir  sludge river ganges  metagenomics  antibiotics  args   heavy metals  mrgs   microbiome  bacteriophages')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "KxQ6zBRXI3BS",
        "outputId": "ea271315-37c6-43bd-f38b-1e9965bb362b"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Aquatic ecosystems are regarded as a hub of antibiotic and metal resistance genes. River Ganges is a unique riverine system in India with socio-cultural and economic significance. However, it remains underexplored for its microbiome and associated resistomes along its anthropogenically impacted course. The present study utilized a nanopore sequencing approach to depict the microbial community structure in the sediments of the river Ganges harboring antibiotic and metal resistance genes (A/MRGs) in lower stretches known for anthropogenic impact. Comprehensive microbiome analyses revealed resistance genes against 23 different types of metals and 28 classes of antibiotics. The most dominant ARG category was multidrug resistance, while the most prevalent MRGs conferred resistance against copper and zinc. Seasonal differences dismally affected the microbiota of the Ganges. However, resistance genes for fosmidomycin and tetracycline varied with season ANOVA, p < 0.05. Interestingly, 333 and 334 ARG subtypes were observed at all the locations in pre-monsoon and post-monsoon, respectively. The taxa associated with the dominant ARGs and MRGs were Pseudomonas and Burkholderia, which are important nosocomial pathogens. A substantial phage diversity for pathogenic and putrefying bacteria at all locations attracts attention for its use to tackle the dissemination of antibiotic and metal-resistant bacteria. This study suggests the accumulation of antibiotics and metals as the driving force for the emergence of resistance genes and the affiliated bacteria trafficking them. The present metagenomic assessment highlights the need for comprehensive, long-term biological and physicochemical monitoring and mitigation strategies toward the contaminants associated with ARGs and MRGs in this nationally important river. "
            ]
          },
          "metadata": {},
          "execution_count": 26
        }
      ],
      "source": [
        "nlp('Aquatic ecosystems are regarded as a hub of antibiotic and metal resistance genes. River Ganges is a unique riverine system in India with socio-cultural and economic significance. However, it remains underexplored for its microbiome and associated resistomes along its anthropogenically impacted course. The present study utilized a nanopore sequencing approach to depict the microbial community structure in the sediments of the river Ganges harboring antibiotic and metal resistance genes (A/MRGs) in lower stretches known for anthropogenic impact. Comprehensive microbiome analyses revealed resistance genes against 23 different types of metals and 28 classes of antibiotics. The most dominant ARG category was multidrug resistance, while the most prevalent MRGs conferred resistance against copper and zinc. Seasonal differences dismally affected the microbiota of the Ganges. However, resistance genes for fosmidomycin and tetracycline varied with season ANOVA, p < 0.05. Interestingly, 333 and 334 ARG subtypes were observed at all the locations in pre-monsoon and post-monsoon, respectively. The taxa associated with the dominant ARGs and MRGs were Pseudomonas and Burkholderia, which are important nosocomial pathogens. A substantial phage diversity for pathogenic and putrefying bacteria at all locations attracts attention for its use to tackle the dissemination of antibiotic and metal-resistant bacteria. This study suggests the accumulation of antibiotics and metals as the driving force for the emergence of resistance genes and the affiliated bacteria trafficking them. The present metagenomic assessment highlights the need for comprehensive, long-term biological and physicochemical monitoring and mitigation strategies toward the contaminants associated with ARGs and MRGs in this nationally important river. ')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "BLhkvJn1grrd",
        "outputId": "722bd31c-f7e3-4141-b257-88d9b7bef6e6"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Staphylococcus aureus"
            ]
          },
          "metadata": {},
          "execution_count": 27
        }
      ],
      "source": [
        "nlp('Staphylococcus aureus')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "oW0_-QwFI3Gn",
        "outputId": "e49c4761-b80d-4ffe-bb96-e570ea2188da"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "0    Rank        Trial ID                                              Title  \\\n",
              "1     675     NCT05948592  A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2     764     NCT05973721  To Investigate the Clinical Efficacy and Safet...   \n",
              "3     622     NCT05967130  Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4     195  ISRCTN18158855  Evaluating the diagnostic utility of Actiphage...   \n",
              "5    1042     NCT05537519  Phage Therapy for the Treatment of Urinary Tra...   \n",
              "..    ...             ...                                                ...   \n",
              "105   407     NCT00001540  The Use of Bacteriophage Phi X174 to Assess th...   \n",
              "106   877     NCT04636554  Expanded Access Study of Phage Treatment in Co...   \n",
              "107   479     NCT03395769  Expanded Access Program for AB-SA01, an Invest...   \n",
              "108   479     NCT03395743  Expanded Access Program for AB-PA01, an Invest...   \n",
              "109   322     NCT00006066  Phase I/II Trial of Subcutaneous IL-2 With Hig...   \n",
              "\n",
              "0                                          Brief title   Acronym  \\\n",
              "1    Bacteriophage Therapy TP-102 in Patients With ...  REVERSE2   \n",
              "2    Clinical Study of Phage Therapy for Chronic Co...       NaN   \n",
              "3         Treatment Chronic UTI Post Kidney Transplant       NaN   \n",
              "4    Evaluating the performance of blood-based test...  PHAGE-TB   \n",
              "5    Phage Therapy for the Treatment of Urinary Tra...       NaN   \n",
              "..                                                 ...       ...   \n",
              "105  The Use of Bacteriophage Phi X174 to Assess th...       NaN   \n",
              "106  Personalized Phage Treatment in Covid-19 Patie...       NaN   \n",
              "107  Individual Patient Expanded Access for AB-SA01...       NaN   \n",
              "108  Individual Patient Expanded Access for AB-PA01...       NaN   \n",
              "109  Interleukin-2 Plus Anti-HIV Therapy in HIV-Inf...       NaN   \n",
              "\n",
              "0                                             Abstract  Start date Start Year  \\\n",
              "1    TP-102 is a novel bacteriophage cocktail compr...  2023-08-01       2023   \n",
              "2    The overall aim was to evaluate the efficacy o...  2023-07-01       2023   \n",
              "3    Urinary tract infections (UTIs) with extended-...  2023-07-01       2023   \n",
              "4    Background and study aims \\nTuberculosis (TB) ...  2023-05-05       2023   \n",
              "5    This is a single-patient, phase I/II clinical ...  2023-05-01       2023   \n",
              "..                                                 ...         ...        ...   \n",
              "105  The objective of this study is to evaluate the...  1996-04-01       1996   \n",
              "106  Phage Treatment in Covid-19 Patients with Bact...         NaN        NaN   \n",
              "107  The purpose of the expanded access program is ...         NaN        NaN   \n",
              "108  The purpose of the expanded access program is ...         NaN        NaN   \n",
              "109  The purpose of this study is to determine the ...         NaN        NaN   \n",
              "\n",
              "0      End Date Completion Year      Phase       Study Type  \\\n",
              "1    2023-12-31            2023    Phase 2   Interventional   \n",
              "2    2023-10-01            2023        NaN   Interventional   \n",
              "3    2024-07-01            2024    Phase 3   Interventional   \n",
              "4    2024-07-30            2024        NaN    Observational   \n",
              "5    2025-12-30            2025  Phase 1/2   Interventional   \n",
              "..          ...             ...        ...              ...   \n",
              "105  2000-03-01            2000        NaN    Observational   \n",
              "106         NaN             NaN        NaN  Expanded access   \n",
              "107         NaN             NaN        NaN  Expanded access   \n",
              "108         NaN             NaN        NaN  Expanded access   \n",
              "109  2006-06-01            2006    Phase 1   Interventional   \n",
              "\n",
              "0                                         Study Design  \\\n",
              "1    Allocation: Randomized; Intervention Model: Pa...   \n",
              "2    Allocation: N/A; Intervention Model: Single Gr...   \n",
              "3    Allocation: N/A; Intervention Model: Single Gr...   \n",
              "4    Allocation: Cohort Study; Primary Purpose: Dia...   \n",
              "5    Allocation: N/A; Intervention Model: Single Gr...   \n",
              "..                                                 ...   \n",
              "105                                                NaN   \n",
              "106                                                NaN   \n",
              "107                                                NaN   \n",
              "108                                                NaN   \n",
              "109                         Primary Purpose: Treatment   \n",
              "\n",
              "0                                           Conditions  \\\n",
              "1                              Diabetic Foot Infection   \n",
              "2         Pib Specific Phage; Intractable Constipation   \n",
              "3    Urinary Tract Infections; Transplant-Related D...   \n",
              "4             Diagnosis of active tuberculosis disease   \n",
              "5                    Recurrent Urinary Tract Infection   \n",
              "..                                                 ...   \n",
              "105                                     HIV Infections   \n",
              "106  Covid19; Bacteremia; Septicemia; Acinetobacter...   \n",
              "107                                                NaN   \n",
              "108                                                NaN   \n",
              "109                                     HIV Infections   \n",
              "\n",
              "0        Recruitment Status Number of Participants  \\\n",
              "1        Not yet recruiting                     80   \n",
              "2                Recruiting                     50   \n",
              "3                Recruiting                     20   \n",
              "4                       NaN                    103   \n",
              "5    Active, not recruiting                      1   \n",
              "..                      ...                    ...   \n",
              "105               Completed                     52   \n",
              "106     No longer available                    NaN   \n",
              "107     No longer available                    NaN   \n",
              "108     No longer available                    NaN   \n",
              "109               Completed                     92   \n",
              "\n",
              "0                                         Intervention  Gender  \\\n",
              "1                 TP-102 (Biological), Placebo (Other)     All   \n",
              "2                                   phage (Biological)     All   \n",
              "3                                   Phage (Biological)     All   \n",
              "4                                                  NaN     All   \n",
              "5                           Phage Therapy (Biological)  Female   \n",
              "..                                                 ...     ...   \n",
              "105                                                NaN     All   \n",
              "106                              Phage Therapy (Other)     All   \n",
              "107                               AB-SA01 (Biological)     All   \n",
              "108                               AB-PA01 (Biological)     All   \n",
              "109  Diphtheria & Tetanus Toxoids & Acellular Pertu...     All   \n",
              "\n",
              "0                    Age            Registry Investigators/Contacts  \\\n",
              "1         18 Years - N/A  ClinicalTrials.gov      Jose David Suarez   \n",
              "2    18 Years - 70 Years  ClinicalTrials.gov         Hongliang Tian   \n",
              "3              N/A - N/A  ClinicalTrials.gov                 Dalili   \n",
              "4            None - None              ISRCTN                    NaN   \n",
              "5         18 Years - N/A  ClinicalTrials.gov         Gregory German   \n",
              "..                   ...                 ...                    ...   \n",
              "105            N/A - N/A  ClinicalTrials.gov                    NaN   \n",
              "106       18 Years - N/A  ClinicalTrials.gov                    NaN   \n",
              "107            N/A - N/A  ClinicalTrials.gov                    NaN   \n",
              "108            N/A - N/A  ClinicalTrials.gov                    NaN   \n",
              "109   2 Years - 18 Years  ClinicalTrials.gov           Savita Pahwa   \n",
              "\n",
              "0                               Sponsors/Collaborators  \\\n",
              "1                           Technophage, SA; VectorB2B   \n",
              "2    Shanghai 10th People's Hospital; Shanghai Tent...   \n",
              "3    Shahid Beheshti University of Medical Sciences...   \n",
              "4    University of Leicester; PBD Biotech Limited; ...   \n",
              "5    Unity Health Toronto; Applied Health Research ...   \n",
              "..                                                 ...   \n",
              "105  National Institute of Allergy and Infectious D...   \n",
              "106                  Adaptive Phage Therapeutics, Inc.   \n",
              "107             Armata Pharmaceuticals (United States)   \n",
              "108             Armata Pharmaceuticals (United States)   \n",
              "109  National Institute of Allergy and Infectious D...   \n",
              "\n",
              "0                                             GRID IDs  \\\n",
              "1                                                   ;    \n",
              "2                                      ; grid.412538.9   \n",
              "3                                      grid.411600.2;    \n",
              "4                         grid.9918.9; ; grid.269014.8   \n",
              "5                                    ; ; grid.416449.a   \n",
              "..                                                 ...   \n",
              "105                       grid.419681.3; grid.419681.3   \n",
              "106                                                NaN   \n",
              "107                                      grid.515996.7   \n",
              "108                                      grid.515996.7   \n",
              "109  grid.419681.3; grid.420089.7; grid.415317.5; ;...   \n",
              "\n",
              "0                         City of Sponsor/Collaborator  \\\n",
              "1                                                   ;    \n",
              "2                                           ; Shanghai   \n",
              "3                                       Tehran; Tehran   \n",
              "4                               Leicester; ; Leicester   \n",
              "5                                          ; ; Toronto   \n",
              "..                                                 ...   \n",
              "105                                 Bethesda; Bethesda   \n",
              "106                                                NaN   \n",
              "107                                     Marina del Rey   \n",
              "108                                     Marina del Rey   \n",
              "109  Bethesda; Bethesda; Long Beach; Los Angeles; S...   \n",
              "\n",
              "0                        State of Sponsor/Collaborator  \\\n",
              "1                                                   ;    \n",
              "2                                                   ;    \n",
              "3                                                   ;    \n",
              "4                                                 ; ;    \n",
              "5                                          ; ; Ontario   \n",
              "..                                                 ...   \n",
              "105                                 Maryland; Maryland   \n",
              "106                                                NaN   \n",
              "107                                         California   \n",
              "108                                         California   \n",
              "109  Maryland; Maryland; California; California; Ca...   \n",
              "\n",
              "0                      Country of Sponsor/Collaborator  \\\n",
              "1                                                   ;    \n",
              "2                                              ; China   \n",
              "3                      Iran; Iran, Islamic Republic of   \n",
              "4                     United Kingdom; ; United Kingdom   \n",
              "5                                           ; ; Canada   \n",
              "..                                                 ...   \n",
              "105                       United States; United States   \n",
              "106                                                NaN   \n",
              "107                                      United States   \n",
              "108                                      United States   \n",
              "109  United States; United States; United States; U...   \n",
              "\n",
              "0                                Collaborating Funders  \\\n",
              "1                                                  NaN   \n",
              "2                                                  NaN   \n",
              "3       Shahid Beheshti University of Medical Sciences   \n",
              "4                              University of Leicester   \n",
              "5                                                  NaN   \n",
              "..                                                 ...   \n",
              "105  National Institute of Allergy and Infectious D...   \n",
              "106                                                NaN   \n",
              "107                                                NaN   \n",
              "108                                                NaN   \n",
              "109  Eunice Kennedy Shriver National Institute of C...   \n",
              "\n",
              "0                                         Funder Group  \\\n",
              "1                                                  NaN   \n",
              "2                                                  NaN   \n",
              "3                                                  NaN   \n",
              "4                                                  NaN   \n",
              "5                                                  NaN   \n",
              "..                                                 ...   \n",
              "105  US Federal Funders; NIH - National Institutes ...   \n",
              "106                                                NaN   \n",
              "107                                                NaN   \n",
              "108                                                NaN   \n",
              "109  US Federal Funders; NIH - National Institutes ...   \n",
              "\n",
              "0                  Funder Country  \\\n",
              "1                             NaN   \n",
              "2                             NaN   \n",
              "3                            Iran   \n",
              "4                  United Kingdom   \n",
              "5                             NaN   \n",
              "..                            ...   \n",
              "105                 United States   \n",
              "106                           NaN   \n",
              "107                           NaN   \n",
              "108                           NaN   \n",
              "109  United States; United States   \n",
              "\n",
              "0                                 Source Linkout Altmetric Attention Score  \\\n",
              "1    https://clinicaltrials.gov/show/NCT05948592                       NaN   \n",
              "2    https://clinicaltrials.gov/show/NCT05973721                       NaN   \n",
              "3    https://clinicaltrials.gov/show/NCT05967130                       NaN   \n",
              "4          https://www.isrctn.com/ISRCTN18158855                       NaN   \n",
              "5    https://clinicaltrials.gov/show/NCT05537519                       247   \n",
              "..                                           ...                       ...   \n",
              "105  https://clinicaltrials.gov/show/NCT00001540                       NaN   \n",
              "106  https://clinicaltrials.gov/show/NCT04636554                       NaN   \n",
              "107  https://clinicaltrials.gov/show/NCT03395769                       NaN   \n",
              "108  https://clinicaltrials.gov/show/NCT03395743                       NaN   \n",
              "109  https://clinicaltrials.gov/show/NCT00006066                       NaN   \n",
              "\n",
              "0                                       Dimensions URL  \\\n",
              "1    https://app.dimensions.ai/details/clinical_tri...   \n",
              "2    https://app.dimensions.ai/details/clinical_tri...   \n",
              "3    https://app.dimensions.ai/details/clinical_tri...   \n",
              "4    https://app.dimensions.ai/details/clinical_tri...   \n",
              "5    https://app.dimensions.ai/details/clinical_tri...   \n",
              "..                                                 ...   \n",
              "105  https://app.dimensions.ai/details/clinical_tri...   \n",
              "106  https://app.dimensions.ai/details/clinical_tri...   \n",
              "107  https://app.dimensions.ai/details/clinical_tri...   \n",
              "108  https://app.dimensions.ai/details/clinical_tri...   \n",
              "109  https://app.dimensions.ai/details/clinical_tri...   \n",
              "\n",
              "0                     Fields of Research (ANZSRC 2020)  \\\n",
              "1    31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "2    32 Biomedical and Clinical Sciences; 3202 Clin...   \n",
              "3    31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "4    4203 Health Services and Systems; 32 Biomedica...   \n",
              "5    3207 Medical Microbiology; 32 Biomedical and C...   \n",
              "..                                                 ...   \n",
              "105  3207 Medical Microbiology; 32 Biomedical and C...   \n",
              "106  31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "107  31 Biological Sciences; 32 Biomedical and Clin...   \n",
              "108  3207 Medical Microbiology; 32 Biomedical and C...   \n",
              "109  3207 Medical Microbiology; 32 Biomedical and C...   \n",
              "\n",
              "0                                      RCDC Categories  \\\n",
              "1    Emerging Infectious Diseases; Clinical Researc...   \n",
              "2                                   Digestive Diseases   \n",
              "3    Urologic Diseases; Infectious Diseases; Transp...   \n",
              "4    Biodefense; Clinical Research; Infectious Dise...   \n",
              "5    Infectious Diseases; Clinical Research; Urolog...   \n",
              "..                                                 ...   \n",
              "105  Infectious Diseases; Clinical Trials and Suppo...   \n",
              "106  Pneumonia; Antimicrobial Resistance; Hematolog...   \n",
              "107  Emerging Infectious Diseases; Infectious Diseases   \n",
              "108                 Infectious Diseases; Rare Diseases   \n",
              "109  HIV/AIDS; Infectious Diseases; Pediatric AIDS;...   \n",
              "\n",
              "0                 HRCS HC Categories  \\\n",
              "1                          Infection   \n",
              "2                                NaN   \n",
              "3    Renal and urogenital; Infection   \n",
              "4                          Infection   \n",
              "5    Infection; Renal and urogenital   \n",
              "..                               ...   \n",
              "105                        Infection   \n",
              "106                        Infection   \n",
              "107                              NaN   \n",
              "108                              NaN   \n",
              "109                        Infection   \n",
              "\n",
              "0                                  HRCS RAC Categories Cancer Types  \\\n",
              "1    5.1 Pharmaceuticals; 6.1 Pharmaceuticals; 6.2 ...          NaN   \n",
              "2                                  5.1 Pharmaceuticals          NaN   \n",
              "3                                                  NaN          NaN   \n",
              "4    4.2 Evaluation of markers and technologies; 4....          NaN   \n",
              "5             6.1 Pharmaceuticals; 5.1 Pharmaceuticals          NaN   \n",
              "..                                                 ...          ...   \n",
              "105                                6.1 Pharmaceuticals          NaN   \n",
              "106                                5.1 Pharmaceuticals          NaN   \n",
              "107                                5.1 Pharmaceuticals          NaN   \n",
              "108                                                NaN          NaN   \n",
              "109           6.1 Pharmaceuticals; 5.1 Pharmaceuticals          NaN   \n",
              "\n",
              "0   CSO Categories                                     Title_Abstract  \\\n",
              "1              NaN  A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2              NaN  To Investigate the Clinical Efficacy and Safet...   \n",
              "3              NaN  Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4              NaN  Evaluating the diagnostic utility of Actiphage...   \n",
              "5              NaN  Phage Therapy for the Treatment of Urinary Tra...   \n",
              "..             ...                                                ...   \n",
              "105            NaN  The Use of Bacteriophage Phi X174 to Assess th...   \n",
              "106            NaN  Expanded Access Study of Phage Treatment in Co...   \n",
              "107            NaN  Expanded Access Program for AB-SA01, an Invest...   \n",
              "108            NaN  Expanded Access Program for AB-PA01, an Invest...   \n",
              "109            NaN  Phase I/II Trial of Subcutaneous IL-2 With Hig...   \n",
              "\n",
              "0                                  Title_Abstract_punc  \\\n",
              "1    A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2    To Investigate the Clinical Efficacy and Safet...   \n",
              "3    Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4    Evaluating the diagnostic utility of Actiphage...   \n",
              "5    Phage Therapy for the Treatment of Urinary Tra...   \n",
              "..                                                 ...   \n",
              "105  The Use of Bacteriophage Phi X174 to Assess th...   \n",
              "106  Expanded Access Study of Phage Treatment in Co...   \n",
              "107  Expanded Access Program for AB SA01  an Invest...   \n",
              "108  Expanded Access Program for AB PA01  an Invest...   \n",
              "109  Phase I II Trial of Subcutaneous IL 2 With Hig...   \n",
              "\n",
              "0                            Title_Abstract_punc_lower  \\\n",
              "1    a phase 2 ct to evaluate the safety and effica...   \n",
              "2    to investigate the clinical efficacy and safet...   \n",
              "3    treatment of chronic relapsing urinary tract i...   \n",
              "4    evaluating the diagnostic utility of actiphage...   \n",
              "5    phage therapy for the treatment of urinary tra...   \n",
              "..                                                 ...   \n",
              "105  the use of bacteriophage phi x174 to assess th...   \n",
              "106  expanded access study of phage treatment in co...   \n",
              "107  expanded access program for ab sa01  an invest...   \n",
              "108  expanded access program for ab pa01  an invest...   \n",
              "109  phase i ii trial of subcutaneous il 2 with hig...   \n",
              "\n",
              "0                                 Title_Abstract_lower  \\\n",
              "1    a phase 2 ct to evaluate the safety and effica...   \n",
              "2    to investigate the clinical efficacy and safet...   \n",
              "3    treatment of chronic relapsing urinary tract i...   \n",
              "4    evaluating the diagnostic utility of actiphage...   \n",
              "5    phage therapy for the treatment of urinary tra...   \n",
              "..                                                 ...   \n",
              "105  the use of bacteriophage phi x174 to assess th...   \n",
              "106  expanded access study of phage treatment in co...   \n",
              "107  expanded access program for ab-sa01, an invest...   \n",
              "108  expanded access program for ab-pa01, an invest...   \n",
              "109  phase i/ii trial of subcutaneous il-2 with hig...   \n",
              "\n",
              "0                                 Title_Abstract_upper  \\\n",
              "1    A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...   \n",
              "2    TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...   \n",
              "3    TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...   \n",
              "4    EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...   \n",
              "5    PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...   \n",
              "..                                                 ...   \n",
              "105  THE USE OF BACTERIOPHAGE PHI X174 TO ASSESS TH...   \n",
              "106  EXPANDED ACCESS STUDY OF PHAGE TREATMENT IN CO...   \n",
              "107  EXPANDED ACCESS PROGRAM FOR AB-SA01, AN INVEST...   \n",
              "108  EXPANDED ACCESS PROGRAM FOR AB-PA01, AN INVEST...   \n",
              "109  PHASE I/II TRIAL OF SUBCUTANEOUS IL-2 WITH HIG...   \n",
              "\n",
              "0                            Title_Abstract_punc_upper  \\\n",
              "1    A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...   \n",
              "2    TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...   \n",
              "3    TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...   \n",
              "4    EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...   \n",
              "5    PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...   \n",
              "..                                                 ...   \n",
              "105  THE USE OF BACTERIOPHAGE PHI X174 TO ASSESS TH...   \n",
              "106  EXPANDED ACCESS STUDY OF PHAGE TREATMENT IN CO...   \n",
              "107  EXPANDED ACCESS PROGRAM FOR AB SA01  AN INVEST...   \n",
              "108  EXPANDED ACCESS PROGRAM FOR AB PA01  AN INVEST...   \n",
              "109  PHASE I II TRIAL OF SUBCUTANEOUS IL 2 WITH HIG...   \n",
              "\n",
              "0                                Title_Abstract_concat  \\\n",
              "1    A Phase 2 CT to Evaluate the Safety and Effica...   \n",
              "2    To Investigate the Clinical Efficacy and Safet...   \n",
              "3    Treatment of Chronic Relapsing Urinary Tract I...   \n",
              "4    Evaluating the diagnostic utility of Actiphage...   \n",
              "5    Phage Therapy for the Treatment of Urinary Tra...   \n",
              "..                                                 ...   \n",
              "105  The Use of Bacteriophage Phi X174 to Assess th...   \n",
              "106  Expanded Access Study of Phage Treatment in Co...   \n",
              "107  Expanded Access Program for AB-SA01, an Invest...   \n",
              "108  Expanded Access Program for AB-PA01, an Invest...   \n",
              "109  Phase I/II Trial of Subcutaneous IL-2 With Hig...   \n",
              "\n",
              "0                                             Diseases  \\\n",
              "1    [Diabetic Foot Infection TP-102, aeruginosa, A...   \n",
              "2    [Chronic Constipation, Chronic Constipation, c...   \n",
              "3    [UTIs, UTIs, urinary tract infections, UTIs, U...   \n",
              "4    [active pulmonary TB, tuberculosis, Tuberculos...   \n",
              "5    [urinary tract infection, urinary tract infect...   \n",
              "..                                                 ...   \n",
              "105  [HIV Infected, HIV Infected, HIV infected, HIV...   \n",
              "106  [Pneumonia, Bacteremia/Septicemia, Aeruginosa,...   \n",
              "107  [Staphylococcus aureus infections, aureus infe...   \n",
              "108  [Aeruginosa, Aeruginosa, Aeruginosa, aeruginos...   \n",
              "109  [HIV infection, HIV infection, HIV infection, ...   \n",
              "\n",
              "0                                       Microorganisms  \n",
              "1    [Patients, Patients, patients, patients, patie...  \n",
              "2    [PiB-specific, patients, patients, patients, p...  \n",
              "3    [Patients, patients, UTIs, cephalosporin-susce...  \n",
              "4    [patients, participants, participants, People,...  \n",
              "5    [bacteriophage, bacteriophage, patient, bacter...  \n",
              "..                                                 ...  \n",
              "105  [Patients, Patients, bacteriophage phi X174, p...  \n",
              "106  [A., patients, A., patients, A., A., Patients,...  \n",
              "107  [Patient, patients, Patient, patients, patient...  \n",
              "108  [Patients, Patient, patients, Patients, Patien...  \n",
              "109  [Children, Children, children, People, people,...  \n",
              "\n",
              "[109 rows x 47 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-fb3bf1d0-b862-443e-8427-b909934980f9\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Rank</th>\n",
              "      <th>Trial ID</th>\n",
              "      <th>Title</th>\n",
              "      <th>Brief title</th>\n",
              "      <th>Acronym</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Start date</th>\n",
              "      <th>Start Year</th>\n",
              "      <th>End Date</th>\n",
              "      <th>Completion Year</th>\n",
              "      <th>Phase</th>\n",
              "      <th>Study Type</th>\n",
              "      <th>Study Design</th>\n",
              "      <th>Conditions</th>\n",
              "      <th>Recruitment Status</th>\n",
              "      <th>Number of Participants</th>\n",
              "      <th>Intervention</th>\n",
              "      <th>Gender</th>\n",
              "      <th>Age</th>\n",
              "      <th>Registry</th>\n",
              "      <th>Investigators/Contacts</th>\n",
              "      <th>Sponsors/Collaborators</th>\n",
              "      <th>GRID IDs</th>\n",
              "      <th>City of Sponsor/Collaborator</th>\n",
              "      <th>State of Sponsor/Collaborator</th>\n",
              "      <th>Country of Sponsor/Collaborator</th>\n",
              "      <th>Collaborating Funders</th>\n",
              "      <th>Funder Group</th>\n",
              "      <th>Funder Country</th>\n",
              "      <th>Source Linkout</th>\n",
              "      <th>Altmetric Attention Score</th>\n",
              "      <th>Dimensions URL</th>\n",
              "      <th>Fields of Research (ANZSRC 2020)</th>\n",
              "      <th>RCDC Categories</th>\n",
              "      <th>HRCS HC Categories</th>\n",
              "      <th>HRCS RAC Categories</th>\n",
              "      <th>Cancer Types</th>\n",
              "      <th>CSO Categories</th>\n",
              "      <th>Title_Abstract</th>\n",
              "      <th>Title_Abstract_punc</th>\n",
              "      <th>Title_Abstract_punc_lower</th>\n",
              "      <th>Title_Abstract_lower</th>\n",
              "      <th>Title_Abstract_upper</th>\n",
              "      <th>Title_Abstract_punc_upper</th>\n",
              "      <th>Title_Abstract_concat</th>\n",
              "      <th>Diseases</th>\n",
              "      <th>Microorganisms</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>675</td>\n",
              "      <td>NCT05948592</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>Bacteriophage Therapy TP-102 in Patients With ...</td>\n",
              "      <td>REVERSE2</td>\n",
              "      <td>TP-102 is a novel bacteriophage cocktail compr...</td>\n",
              "      <td>2023-08-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2023-12-31</td>\n",
              "      <td>2023</td>\n",
              "      <td>Phase 2</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: Randomized; Intervention Model: Pa...</td>\n",
              "      <td>Diabetic Foot Infection</td>\n",
              "      <td>Not yet recruiting</td>\n",
              "      <td>80</td>\n",
              "      <td>TP-102 (Biological), Placebo (Other)</td>\n",
              "      <td>All</td>\n",
              "      <td>18 Years - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Jose David Suarez</td>\n",
              "      <td>Technophage, SA; VectorB2B</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>;</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05948592</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Emerging Infectious Diseases; Clinical Researc...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>5.1 Pharmaceuticals; 6.1 Pharmaceuticals; 6.2 ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>a phase 2 ct to evaluate the safety and effica...</td>\n",
              "      <td>a phase 2 ct to evaluate the safety and effica...</td>\n",
              "      <td>A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...</td>\n",
              "      <td>A PHASE 2 CT TO EVALUATE THE SAFETY AND EFFICA...</td>\n",
              "      <td>A Phase 2 CT to Evaluate the Safety and Effica...</td>\n",
              "      <td>[Diabetic Foot Infection TP-102, aeruginosa, A...</td>\n",
              "      <td>[Patients, Patients, patients, patients, patie...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>764</td>\n",
              "      <td>NCT05973721</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>Clinical Study of Phage Therapy for Chronic Co...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The overall aim was to evaluate the efficacy o...</td>\n",
              "      <td>2023-07-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2023-10-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Pib Specific Phage; Intractable Constipation</td>\n",
              "      <td>Recruiting</td>\n",
              "      <td>50</td>\n",
              "      <td>phage (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>18 Years - 70 Years</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Hongliang Tian</td>\n",
              "      <td>Shanghai 10th People's Hospital; Shanghai Tent...</td>\n",
              "      <td>; grid.412538.9</td>\n",
              "      <td>; Shanghai</td>\n",
              "      <td>;</td>\n",
              "      <td>; China</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05973721</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>32 Biomedical and Clinical Sciences; 3202 Clin...</td>\n",
              "      <td>Digestive Diseases</td>\n",
              "      <td>NaN</td>\n",
              "      <td>5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>to investigate the clinical efficacy and safet...</td>\n",
              "      <td>to investigate the clinical efficacy and safet...</td>\n",
              "      <td>TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...</td>\n",
              "      <td>TO INVESTIGATE THE CLINICAL EFFICACY AND SAFET...</td>\n",
              "      <td>To Investigate the Clinical Efficacy and Safet...</td>\n",
              "      <td>[Chronic Constipation, Chronic Constipation, c...</td>\n",
              "      <td>[PiB-specific, patients, patients, patients, p...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>622</td>\n",
              "      <td>NCT05967130</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>Treatment Chronic UTI Post Kidney Transplant</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Urinary tract infections (UTIs) with extended-...</td>\n",
              "      <td>2023-07-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2024-07-01</td>\n",
              "      <td>2024</td>\n",
              "      <td>Phase 3</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Urinary Tract Infections; Transplant-Related D...</td>\n",
              "      <td>Recruiting</td>\n",
              "      <td>20</td>\n",
              "      <td>Phage (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>N/A - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Dalili</td>\n",
              "      <td>Shahid Beheshti University of Medical Sciences...</td>\n",
              "      <td>grid.411600.2;</td>\n",
              "      <td>Tehran; Tehran</td>\n",
              "      <td>;</td>\n",
              "      <td>Iran; Iran, Islamic Republic of</td>\n",
              "      <td>Shahid Beheshti University of Medical Sciences</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Iran</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05967130</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Urologic Diseases; Infectious Diseases; Transp...</td>\n",
              "      <td>Renal and urogenital; Infection</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>treatment of chronic relapsing urinary tract i...</td>\n",
              "      <td>treatment of chronic relapsing urinary tract i...</td>\n",
              "      <td>TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...</td>\n",
              "      <td>TREATMENT OF CHRONIC RELAPSING URINARY TRACT I...</td>\n",
              "      <td>Treatment of Chronic Relapsing Urinary Tract I...</td>\n",
              "      <td>[UTIs, UTIs, urinary tract infections, UTIs, U...</td>\n",
              "      <td>[Patients, patients, UTIs, cephalosporin-susce...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>195</td>\n",
              "      <td>ISRCTN18158855</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>Evaluating the performance of blood-based test...</td>\n",
              "      <td>PHAGE-TB</td>\n",
              "      <td>Background and study aims \\nTuberculosis (TB) ...</td>\n",
              "      <td>2023-05-05</td>\n",
              "      <td>2023</td>\n",
              "      <td>2024-07-30</td>\n",
              "      <td>2024</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Observational</td>\n",
              "      <td>Allocation: Cohort Study; Primary Purpose: Dia...</td>\n",
              "      <td>Diagnosis of active tuberculosis disease</td>\n",
              "      <td>NaN</td>\n",
              "      <td>103</td>\n",
              "      <td>NaN</td>\n",
              "      <td>All</td>\n",
              "      <td>None - None</td>\n",
              "      <td>ISRCTN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>University of Leicester; PBD Biotech Limited; ...</td>\n",
              "      <td>grid.9918.9; ; grid.269014.8</td>\n",
              "      <td>Leicester; ; Leicester</td>\n",
              "      <td>; ;</td>\n",
              "      <td>United Kingdom; ; United Kingdom</td>\n",
              "      <td>University of Leicester</td>\n",
              "      <td>NaN</td>\n",
              "      <td>United Kingdom</td>\n",
              "      <td>https://www.isrctn.com/ISRCTN18158855</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>4203 Health Services and Systems; 32 Biomedica...</td>\n",
              "      <td>Biodefense; Clinical Research; Infectious Dise...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>4.2 Evaluation of markers and technologies; 4....</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>evaluating the diagnostic utility of actiphage...</td>\n",
              "      <td>evaluating the diagnostic utility of actiphage...</td>\n",
              "      <td>EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...</td>\n",
              "      <td>EVALUATING THE DIAGNOSTIC UTILITY OF ACTIPHAGE...</td>\n",
              "      <td>Evaluating the diagnostic utility of Actiphage...</td>\n",
              "      <td>[active pulmonary TB, tuberculosis, Tuberculos...</td>\n",
              "      <td>[patients, participants, participants, People,...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>1042</td>\n",
              "      <td>NCT05537519</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>This is a single-patient, phase I/II clinical ...</td>\n",
              "      <td>2023-05-01</td>\n",
              "      <td>2023</td>\n",
              "      <td>2025-12-30</td>\n",
              "      <td>2025</td>\n",
              "      <td>Phase 1/2</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Allocation: N/A; Intervention Model: Single Gr...</td>\n",
              "      <td>Recurrent Urinary Tract Infection</td>\n",
              "      <td>Active, not recruiting</td>\n",
              "      <td>1</td>\n",
              "      <td>Phage Therapy (Biological)</td>\n",
              "      <td>Female</td>\n",
              "      <td>18 Years - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Gregory German</td>\n",
              "      <td>Unity Health Toronto; Applied Health Research ...</td>\n",
              "      <td>; ; grid.416449.a</td>\n",
              "      <td>; ; Toronto</td>\n",
              "      <td>; ; Ontario</td>\n",
              "      <td>; ; Canada</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT05537519</td>\n",
              "      <td>247</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>3207 Medical Microbiology; 32 Biomedical and C...</td>\n",
              "      <td>Infectious Diseases; Clinical Research; Urolog...</td>\n",
              "      <td>Infection; Renal and urogenital</td>\n",
              "      <td>6.1 Pharmaceuticals; 5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>phage therapy for the treatment of urinary tra...</td>\n",
              "      <td>phage therapy for the treatment of urinary tra...</td>\n",
              "      <td>PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...</td>\n",
              "      <td>PHAGE THERAPY FOR THE TREATMENT OF URINARY TRA...</td>\n",
              "      <td>Phage Therapy for the Treatment of Urinary Tra...</td>\n",
              "      <td>[urinary tract infection, urinary tract infect...</td>\n",
              "      <td>[bacteriophage, bacteriophage, patient, bacter...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>105</th>\n",
              "      <td>407</td>\n",
              "      <td>NCT00001540</td>\n",
              "      <td>The Use of Bacteriophage Phi X174 to Assess th...</td>\n",
              "      <td>The Use of Bacteriophage Phi X174 to Assess th...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The objective of this study is to evaluate the...</td>\n",
              "      <td>1996-04-01</td>\n",
              "      <td>1996</td>\n",
              "      <td>2000-03-01</td>\n",
              "      <td>2000</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Observational</td>\n",
              "      <td>NaN</td>\n",
              "      <td>HIV Infections</td>\n",
              "      <td>Completed</td>\n",
              "      <td>52</td>\n",
              "      <td>NaN</td>\n",
              "      <td>All</td>\n",
              "      <td>N/A - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>NaN</td>\n",
              "      <td>National Institute of Allergy and Infectious D...</td>\n",
              "      <td>grid.419681.3; grid.419681.3</td>\n",
              "      <td>Bethesda; Bethesda</td>\n",
              "      <td>Maryland; Maryland</td>\n",
              "      <td>United States; United States</td>\n",
              "      <td>National Institute of Allergy and Infectious D...</td>\n",
              "      <td>US Federal Funders; NIH - National Institutes ...</td>\n",
              "      <td>United States</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT00001540</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>3207 Medical Microbiology; 32 Biomedical and C...</td>\n",
              "      <td>Infectious Diseases; Clinical Trials and Suppo...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>6.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The Use of Bacteriophage Phi X174 to Assess th...</td>\n",
              "      <td>The Use of Bacteriophage Phi X174 to Assess th...</td>\n",
              "      <td>the use of bacteriophage phi x174 to assess th...</td>\n",
              "      <td>the use of bacteriophage phi x174 to assess th...</td>\n",
              "      <td>THE USE OF BACTERIOPHAGE PHI X174 TO ASSESS TH...</td>\n",
              "      <td>THE USE OF BACTERIOPHAGE PHI X174 TO ASSESS TH...</td>\n",
              "      <td>The Use of Bacteriophage Phi X174 to Assess th...</td>\n",
              "      <td>[HIV Infected, HIV Infected, HIV infected, HIV...</td>\n",
              "      <td>[Patients, Patients, bacteriophage phi X174, p...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>106</th>\n",
              "      <td>877</td>\n",
              "      <td>NCT04636554</td>\n",
              "      <td>Expanded Access Study of Phage Treatment in Co...</td>\n",
              "      <td>Personalized Phage Treatment in Covid-19 Patie...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Phage Treatment in Covid-19 Patients with Bact...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Expanded access</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Covid19; Bacteremia; Septicemia; Acinetobacter...</td>\n",
              "      <td>No longer available</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Phage Therapy (Other)</td>\n",
              "      <td>All</td>\n",
              "      <td>18 Years - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Adaptive Phage Therapeutics, Inc.</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT04636554</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Pneumonia; Antimicrobial Resistance; Hematolog...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Expanded Access Study of Phage Treatment in Co...</td>\n",
              "      <td>Expanded Access Study of Phage Treatment in Co...</td>\n",
              "      <td>expanded access study of phage treatment in co...</td>\n",
              "      <td>expanded access study of phage treatment in co...</td>\n",
              "      <td>EXPANDED ACCESS STUDY OF PHAGE TREATMENT IN CO...</td>\n",
              "      <td>EXPANDED ACCESS STUDY OF PHAGE TREATMENT IN CO...</td>\n",
              "      <td>Expanded Access Study of Phage Treatment in Co...</td>\n",
              "      <td>[Pneumonia, Bacteremia/Septicemia, Aeruginosa,...</td>\n",
              "      <td>[A., patients, A., patients, A., A., Patients,...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>107</th>\n",
              "      <td>479</td>\n",
              "      <td>NCT03395769</td>\n",
              "      <td>Expanded Access Program for AB-SA01, an Invest...</td>\n",
              "      <td>Individual Patient Expanded Access for AB-SA01...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The purpose of the expanded access program is ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Expanded access</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>No longer available</td>\n",
              "      <td>NaN</td>\n",
              "      <td>AB-SA01 (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>N/A - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Armata Pharmaceuticals (United States)</td>\n",
              "      <td>grid.515996.7</td>\n",
              "      <td>Marina del Rey</td>\n",
              "      <td>California</td>\n",
              "      <td>United States</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT03395769</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>31 Biological Sciences; 32 Biomedical and Clin...</td>\n",
              "      <td>Emerging Infectious Diseases; Infectious Diseases</td>\n",
              "      <td>NaN</td>\n",
              "      <td>5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Expanded Access Program for AB-SA01, an Invest...</td>\n",
              "      <td>Expanded Access Program for AB SA01  an Invest...</td>\n",
              "      <td>expanded access program for ab sa01  an invest...</td>\n",
              "      <td>expanded access program for ab-sa01, an invest...</td>\n",
              "      <td>EXPANDED ACCESS PROGRAM FOR AB-SA01, AN INVEST...</td>\n",
              "      <td>EXPANDED ACCESS PROGRAM FOR AB SA01  AN INVEST...</td>\n",
              "      <td>Expanded Access Program for AB-SA01, an Invest...</td>\n",
              "      <td>[Staphylococcus aureus infections, aureus infe...</td>\n",
              "      <td>[Patient, patients, Patient, patients, patient...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>108</th>\n",
              "      <td>479</td>\n",
              "      <td>NCT03395743</td>\n",
              "      <td>Expanded Access Program for AB-PA01, an Invest...</td>\n",
              "      <td>Individual Patient Expanded Access for AB-PA01...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The purpose of the expanded access program is ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Expanded access</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>No longer available</td>\n",
              "      <td>NaN</td>\n",
              "      <td>AB-PA01 (Biological)</td>\n",
              "      <td>All</td>\n",
              "      <td>N/A - N/A</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Armata Pharmaceuticals (United States)</td>\n",
              "      <td>grid.515996.7</td>\n",
              "      <td>Marina del Rey</td>\n",
              "      <td>California</td>\n",
              "      <td>United States</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT03395743</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>3207 Medical Microbiology; 32 Biomedical and C...</td>\n",
              "      <td>Infectious Diseases; Rare Diseases</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Expanded Access Program for AB-PA01, an Invest...</td>\n",
              "      <td>Expanded Access Program for AB PA01  an Invest...</td>\n",
              "      <td>expanded access program for ab pa01  an invest...</td>\n",
              "      <td>expanded access program for ab-pa01, an invest...</td>\n",
              "      <td>EXPANDED ACCESS PROGRAM FOR AB-PA01, AN INVEST...</td>\n",
              "      <td>EXPANDED ACCESS PROGRAM FOR AB PA01  AN INVEST...</td>\n",
              "      <td>Expanded Access Program for AB-PA01, an Invest...</td>\n",
              "      <td>[Aeruginosa, Aeruginosa, Aeruginosa, aeruginos...</td>\n",
              "      <td>[Patients, Patient, patients, Patients, Patien...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>109</th>\n",
              "      <td>322</td>\n",
              "      <td>NCT00006066</td>\n",
              "      <td>Phase I/II Trial of Subcutaneous IL-2 With Hig...</td>\n",
              "      <td>Interleukin-2 Plus Anti-HIV Therapy in HIV-Inf...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The purpose of this study is to determine the ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2006-06-01</td>\n",
              "      <td>2006</td>\n",
              "      <td>Phase 1</td>\n",
              "      <td>Interventional</td>\n",
              "      <td>Primary Purpose: Treatment</td>\n",
              "      <td>HIV Infections</td>\n",
              "      <td>Completed</td>\n",
              "      <td>92</td>\n",
              "      <td>Diphtheria &amp; Tetanus Toxoids &amp; Acellular Pertu...</td>\n",
              "      <td>All</td>\n",
              "      <td>2 Years - 18 Years</td>\n",
              "      <td>ClinicalTrials.gov</td>\n",
              "      <td>Savita Pahwa</td>\n",
              "      <td>National Institute of Allergy and Infectious D...</td>\n",
              "      <td>grid.419681.3; grid.420089.7; grid.415317.5; ;...</td>\n",
              "      <td>Bethesda; Bethesda; Long Beach; Los Angeles; S...</td>\n",
              "      <td>Maryland; Maryland; California; California; Ca...</td>\n",
              "      <td>United States; United States; United States; U...</td>\n",
              "      <td>Eunice Kennedy Shriver National Institute of C...</td>\n",
              "      <td>US Federal Funders; NIH - National Institutes ...</td>\n",
              "      <td>United States; United States</td>\n",
              "      <td>https://clinicaltrials.gov/show/NCT00006066</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://app.dimensions.ai/details/clinical_tri...</td>\n",
              "      <td>3207 Medical Microbiology; 32 Biomedical and C...</td>\n",
              "      <td>HIV/AIDS; Infectious Diseases; Pediatric AIDS;...</td>\n",
              "      <td>Infection</td>\n",
              "      <td>6.1 Pharmaceuticals; 5.1 Pharmaceuticals</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Phase I/II Trial of Subcutaneous IL-2 With Hig...</td>\n",
              "      <td>Phase I II Trial of Subcutaneous IL 2 With Hig...</td>\n",
              "      <td>phase i ii trial of subcutaneous il 2 with hig...</td>\n",
              "      <td>phase i/ii trial of subcutaneous il-2 with hig...</td>\n",
              "      <td>PHASE I/II TRIAL OF SUBCUTANEOUS IL-2 WITH HIG...</td>\n",
              "      <td>PHASE I II TRIAL OF SUBCUTANEOUS IL 2 WITH HIG...</td>\n",
              "      <td>Phase I/II Trial of Subcutaneous IL-2 With Hig...</td>\n",
              "      <td>[HIV infection, HIV infection, HIV infection, ...</td>\n",
              "      <td>[Children, Children, children, People, people,...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>109 rows  47 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-fb3bf1d0-b862-443e-8427-b909934980f9')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-fb3bf1d0-b862-443e-8427-b909934980f9 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-fb3bf1d0-b862-443e-8427-b909934980f9');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-a1a9946f-966a-48fe-8261-c253ab53d50d\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-a1a9946f-966a-48fe-8261-c253ab53d50d')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-a1a9946f-966a-48fe-8261-c253ab53d50d button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 28
        }
      ],
      "source": [
        "df"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "d6_JoHe-y3oT"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 179
        },
        "id": "Visv2GKizASa",
        "outputId": "984efad0-cd1b-40ae-e3ef-704d96d8ad4a"
      },
      "outputs": [
        {
          "output_type": "error",
          "ename": "NameError",
          "evalue": "ignored",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-29-0f5648584fb0>\u001b[0m in \u001b[0;36m<cell line: 1>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
            "\u001b[0;31mNameError\u001b[0m: name 'xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx' is not defined"
          ]
        }
      ],
      "source": [
        "xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "C6L9sMzezAuR"
      },
      "source": [
        "https://github.com/nleguillarme/taxonerd"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "dJSp0VO8y3uP"
      },
      "outputs": [],
      "source": [
        "import spacy\n",
        "import json"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "v8TPkAwDCCoP"
      },
      "outputs": [],
      "source": [
        "from tqdm.notebook import trange, tqdm"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "sFDwSF-8CCsn"
      },
      "outputs": [],
      "source": [
        "from spacy.language import Language"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "HDR3bvJGCCwa"
      },
      "outputs": [],
      "source": [
        "from taxonerd import TaxoNERD"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "IHxutCOPCC0e"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "lFU__N1TCC4b"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "k0vtOP1uy3xW"
      },
      "outputs": [],
      "source": [
        "#pip install https://github.com/nleguillarme/taxonerd/releases/download/v1.5.0/en_core_eco_md-1.0.2.tar.gz"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "VVDqtI5Az0lB"
      },
      "outputs": [],
      "source": [
        "pip install https://github.com/nleguillarme/taxonerd/releases/download/v1.5.0/en_core_eco_biobert-1.0.2.tar.gz"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "GNx7Wy-Py30k"
      },
      "outputs": [],
      "source": [
        "#pip install https://github.com/nleguillarme/taxonerd/releases/download/v1.5.0/en_core_eco_weak_biobert-1.0.0.tar.gz"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "z_3iTSXIy324"
      },
      "outputs": [],
      "source": [
        "#pip install https://github.com/nleguillarme/taxonerd/releases/download/v1.5.0/en_core_eco_weak_md-1.0.0.tar.gz\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "XqiIsQLTCPd5"
      },
      "outputs": [],
      "source": [
        "taxonerd = TaxoNERD(prefer_gpu=True)\n",
        "nlp = taxonerd.load(model=\"en_core_eco_biobert\", exclude=[\"pysbd_sentencizer\", \"parser\"])\n",
        "taxonerd.nlp.pipe_names"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Lkc5s6eEFBfH"
      },
      "outputs": [],
      "source": [
        "text = \"\"\"A study on pathological effects of Acholeplasma laidlawii isolated from buffaloes in Mice Model.\n",
        "-- Respiratory distress has become a hot issue that is causing severe infection in livestock industry of Pakistan.\n",
        "The exact and timely diagnosis is incredible to treat the disease. However, Acholeplasma (A.) laidlawii is found\n",
        "very significant from buffalo lungs but being a ubiquitous organism, its pathogenic description is not completely\n",
        "understood. The study was designed to validate the involvement of A. laidlawii in respiratory diseases in buffaloes.\n",
        "For this purpose, experimental trials on mice were conducted to confirm the involvement of the organism in\n",
        "respiratory tract infection. It was re-isolated from experimentally infected mice, showing lesions in respiratory\n",
        "tract (83.3%), proving Koch's postulates. Statistically, the experimental group-A (subcutaneous route) showed\n",
        "significant difference (P < 0.05) except in case of mortality feature. The group-B (intraperitoneal route)\n",
        "indicated non-significant difference (P>0.05) in all cases. Based on current study, it may be concluded that the\n",
        "organism is opportunistic, and can produce either disease or lesions on targeted organs in stressed animals,\n",
        "particularly buffaloes.\"\"\"\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "0igePTGrCPjD"
      },
      "outputs": [],
      "source": [
        "taxonerd.find_in_text(text)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "lmb84EQBCP3b"
      },
      "outputs": [],
      "source": [
        "doc = nlp(text)\n",
        "Taxons = doc.ents\n",
        "Taxons"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Nythcba3CP62"
      },
      "outputs": [],
      "source": [
        "def extract_taxons(text):\n",
        "    doc = nlp(text)\n",
        "    Taxons = doc.ents\n",
        "    return Taxons"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "3npo6g7_WPGF"
      },
      "outputs": [],
      "source": [
        "extract_taxons(text)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "nvdWgZkuWPJx"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "7mdDKmzfy38y"
      },
      "outputs": [],
      "source": [
        "def extract_taxons(text):\n",
        "    doc = nlp(text)\n",
        "    Taxons = doc.ents\n",
        "    return Taxons\n",
        "\n",
        "# Assuming df is your DataFrame with concatenated titles and abstracts\n",
        "df['Taxons'] = df['Title_Abstract_concat'].apply(extract_taxons)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "BlqMdN4beeRB"
      },
      "outputs": [],
      "source": [
        "df"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "1opEBVS9eeUb"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "rNzUg9NMexpX"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "uBwntBEfexrx"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "vxPwywgbexuI"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "pEU5cCjSexxm"
      },
      "outputs": [],
      "source": [
        "xxxxxxxxxxxxxxxxxx"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "mDxgRkL9y4AH"
      },
      "outputs": [],
      "source": [
        "from taxonerd import TaxoNERD\n",
        "taxonerd = TaxoNERD(prefer_gpu=True)\n",
        "#nlp = taxonerd.load(model=\"en_core_eco_biobert\")\n",
        "doc = nlp(\"Brown bears (Ursus arctos), which are widely distributed throughout the northern hemisphere, are recognised as opportunistic omnivore\")\n",
        "doc.ents"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "pUhB65x4a1_R"
      },
      "outputs": [],
      "source": [
        "import spacy\n",
        "\n",
        "# Load the scispaCy model\n",
        "nlp = spacy.load(\"en_ner_bionlp13cg_md\")\n",
        "\n",
        "def extract_microorganisms(text):\n",
        "    doc = nlp(text)\n",
        "    microorganisms = [ent.text for ent in doc.ents if ent.label_ == \"ORGANISM\"]\n",
        "    return microorganisms\n",
        "\n",
        "# Assuming df is your DataFrame with concatenated titles and abstracts\n",
        "df['Microorganisms'] = df['Title_Abstract_concat'].apply(extract_microorganisms)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "LgWqQKHHI3KF"
      },
      "outputs": [],
      "source": [
        "dddd"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "7b02VVK0I3NJ"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "JYR3AAYM5y2A"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "bN_vhjVQfN47"
      },
      "outputs": [],
      "source": [
        "df = df[(~pd.isnull(df['Abstract'])) & (~pd.isnull(df['Article Title'])) & (~pd.isnull(df['Keywords Plus']))]\n",
        "len(df)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "taAS0BuOLE4B"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "QZW6MAnWJb-U"
      },
      "outputs": [],
      "source": [
        "df = df.set_index(['UT (Unique WOS ID)','Publication Year'])\n",
        "df"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "uKGLPuT85k3T"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "R5mgLGf95k6c"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ES74FTtW5k9d"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "tsh57vr95lAQ"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "RqbOycXU5lDG"
      },
      "outputs": [],
      "source": []
    }
  ],
  "metadata": {
    "colab": {
      "provenance": [],
      "include_colab_link": true
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}